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Introduction
The role of cognitive control in substance dependence is em-
phasized in several contemporary theoretical models.1–6 Indi-
viduals with substance dependence are characterized by the
inability to adequately inhibit behaviour related to substance
use, such as abstaining from substances of abuse. In addition,
an apparent failure to adaptively learn from previous harmful
behaviour seems characteristic for individuals with substance
dependence.7 Inhibitory control and error processing are
2 core components of cognitive control that are associated
with specific neural networks: inhibitory control to implement
the inhibition of inappropriate behaviour and error process-
ing to monitor performance errors to prevent future mistakes.8
Greater insight into the malfunction of neural networks in in-
dividuals with substance dependence underlying inhibitory
control and error processing could provide valuable informa-
tion for understanding the problems associated with control-
ling substance use. Consequently, a rapidly increasing num-
ber of studies have examined inhibitory control and error
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Background: Several current theories emphasize the role of cognitive control in addiction. The present review evaluates neural deficits
in the domains of inhibitory control and error processing in individuals with substance dependence and in those showing excessive
 addiction-like behaviours. The combined evaluation of event-related potential (ERP) and functional magnetic resonance imaging (fMRI)
findings in the present review offers unique information on neural deficits in addicted individuals. Methods: We selected 19 ERP and
22 fMRI studies using stop-signal, go/no-go or Flanker paradigms based on a search of PubMed and Embase. Results: The most con-
sistent findings in addicted individuals relative to healthy controls were lower N2, error-related negativity and error positivity amplitudes
as well as hypoactivation in the anterior cingulate cortex (ACC), inferior frontal gyrus and dorsolateral prefrontal cortex. These neural
deficits, however, were not always associated with impaired task performance. With regard to behavioural addictions, some evidence
has been found for similar neural deficits; however, studies are scarce and results are not yet conclusive. Differences among the major
classes of substances of abuse were identified and involve stronger neural responses to errors in individuals with alcohol dependence
versus weaker neural responses to errors in other substance-dependent populations. Limitations: Task design and analysis techniques
vary across studies, thereby reducing comparability among studies and the potential of clinical use of these measures. Conclusion:
Current addiction theories were supported by identifying consistent abnormalities in prefrontal brain function in individuals with addiction.
An integrative model is proposed, suggesting that neural deficits in the dorsal ACC may constitute a hallmark neurocognitive deficit
under lying addictive behaviours, such as loss of control.
processing in individuals with substance dependence by
 using neuroimaging techniques, such as event-related poten-
tials (ERPs) and functional magnetic resonance imaging
(fMRI). A combined review of ERP and fMRI studies may
provide valuable and complementary insights on both tem -
poral and spatial properties of the neural substrate of prob-
lems associated with inhibitory control and error processing
in individuals with substance dependence. Therefore, the
main aim of the present review is to evaluate the consistency
of findings of fMRI and ERP studies investigating inhibitory
control and error processing in the major classes of substance-
dependent populations.
A second goal of this review is to contribute to the ongoing
discussion about the differences and similarities between
substance dependence and other excessive behaviours that
have been proposed to be related to addiction but that do not
involve the ingestion of substances.9 For example, pathologic -
al gambling is characterized by unsuccessful efforts to con-
trol, cut back or stop gambling, similar to problems control-
ling substance use. Based on these and other similarities,10–12
pathological gambling is listed under the heading “substance
use and addictive disorders” in DSM-5. Other suggested be-
havioural addictions, such as excessive eating,13 computer
game playing or Internet use9 are not included as behavioural
addictions in DSM-5 because of a current lack of sufficient
scientific evidence for similar dysfunctions in people with
these behaviours and those with substance dependence. To
contribute to this ongoing discussion and to identify possible
gaps in the literature, we systematically reviewed neuro -
imaging studies that investigated inhibitory control and error
processing in people with pathological gambling and those
with excessive eating, gaming or Internet use. Throughout
this paper, the term “addiction” refers to both substance
depend ence and the proposed behavioural addictions.
This review starts with an explanation of the experimental
task paradigms most frequently used to measure inhibitory
control and error processing. In addition, neural correlates of
inhibitory control and error processing are discussed to pro-
vide a framework for the evaluation of empirical studies. The
literature review is organized according to primary substance
of abuse (i.e., nicotine, alcohol, cannabis, stimulants and opi-
oids), with a separate section for excessive addiction-like be-
haviours. This review will conclude with a discussion of the
findings, including an integrative model of the findings and
future research directions.
Experimental measures and neural correlates 
of inhibitory control and error processing
Inhibitory control
Experimental measures of inhibitory control
The go/no-go and stop-signal tasks are most commonly used
to measure inhibitory control.14–16 In the go/no-go task, par -
tici pants respond as quickly as possible to frequent go stimuli
and inhibit responses to infrequent no-go stimuli, which re-
quires inhibitory control to overcome automatic response
tendencies. The proportion of correctly inhibited no-go trials
reflects the ability to inhibit automatic behaviour. The stop-
signal paradigm17 measures the ability to exert inhibitory con-
trol over a response that has already been initiated by asking
participants to respond as quickly as possible to a continuous
stream of go stimuli. In a minority of the trials, a stop signal
is presented after the onset of the primary stimulus indicat-
ing that the response to this stimulus should be cancelled.
The ability to inhibit already initiated behaviour is indexed
by the stop-signal reaction time (SSRT), which is the time
needed to cancel 50% of the stop trials relative to mean reac-
tion time for go stimuli. Larger SSRTs represent worse in-
hibitory control. Most stop-signal paradigms use a staircase
method, implying that the number of errors in the task is de-
liberately kept constant to calculate the SSRT. Although we
believe that both the go/no-go and the stop-signal tasks re-
quire the activation of a common inhibitory brake, we are
also aware that more general processes, such as attentional
monitoring and salience processing, may play a role in these
tasks.18–20 Besides the go/no-go and the stop-signal tasks,
other cognitive paradigms, such as the Stroop21 and  Eriksen
Flanker22 tasks have been argued to measure inhibitory ca-
pacities. However, these tasks also measure other processes,
such as conflict resolution, response selection and atten-
tion.23,24 To keep the present review focused and to be able to
make straightforward comparisons of results, we included
only studies using go/no-go and stop-signal paradigms.
Event-related potential measures of inhibitory control
Two ERP components have been reported to reflect changes
in brain activity related to inhibitory control.25 The first com-
ponent, the N2, is a negative-going wave emerging 200–
300 ms after stimulus presentation. The neural generators of
the N2 appear include the anterior cingulate cortex (ACC)25–27
and the right inferior frontal gyrus (IFG).28 The N2 is believed
to index a top–down mechanism needed to inhibit the auto-
matic tendency to respond29,30 and corresponds to behavioural
outcomes of inhibitory control.31–33 The N2 has further been
associated with conflict detection during early stages of the
inhibition process.27,29 Consequently, the N2 can be inter-
preted as an index for early cognitive processes necessary to
implement inhibitory control rather than the actual inhibitory
brake. The P3, the second ERP component involved in in-
hibitory control, is a positive-going wave emerging 300–
500 ms after stimulus onset. The source of the P3 has been
found to be close to motor and premotor cortices.25,26,34 Hence,
P3 amplitudes appear to reflect a later stage of the inhibitory
process closely related to the actual inhibition of the motor
system in the premotor cortex.25,33,35 Together, accumulating
evidence suggests that the N2 and P3 reflect functionally dis-
tinct processes associated with inhibitory control. Accord-
ingly, less pronounced N2 or P3 amplitudes in addicted
popu lations relative to controls can be considered markers
for neural deficits in inhibitory control.
Functional MRI measures of inhibitory control
Inhibitory control in healthy individuals is associated with
a mainly right lateralized network, including the IFG,
Luijten et al.
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ACC/pre–supplementary motor area (SMA) and dorsolat-
eral prefrontal cortex (DLPFC) as well as parietal and subcor-
tical areas, including the thalamus and basal ganglia.15,36,37 Ex-
perimental studies have provided information on the specific
contribution of these regions in implementing inhibitory con-
trol. A recent hypothesis suggests that the right IFG, in in-
hibitory control, detects behaviourally relevant stimuli (e.g.,
no-go or stop-signal stimuli) in cooperation with the inferior
parietal lobe (IPL) and temporal parietal junction (TPJ)
through its effects on stimulus-driven attention, which is a
crucial element of both go/no-go and stop-signal task per -
form ance.18–20 Given the proximity of the pre-SMA/dorsal
ACC (dACC) to the motor areas, the function of this region
may be response selection and updating motor plans.38 In
 addition to frontal and parietal regions, the involvement of
subcortical regions in inhibitory control is well established
through feedback loops that connect these regions with pre-
frontal and motor areas.15,36,39 As an extensive basis of fMRI
studies has consistently shown that activation in this
 cortical–striatal– thalamic network is linked to inhibitory con-
trol in healthy participants, differences in brain activation in
this network during the performance of inhibitory control
paradigms in individuals with addictions relative to controls
can be interpreted as the presence of neural deficits in
 inhibitory control in these individuals.
Error processing
Experimental measures of error processing
The most commonly used paradigms are the Eriksen Flanker
and the go/no-go task.40,41 In a typical version of the Flanker
task, participants are exposed to series of letters. In the con-
gruent condition, 5 equal letters are presented, while in the
incongruent condition the middle letter differs from the other
letters (e.g, SSHSS/HHSHH). Participants are asked to iden-
tify the middle letter. The high stimulus conflict situation in
the incongruent condition usually results in performance
 errors. False-positive errors observed in go/no-go or stop-
 signal paradigms, are also used to evaluate error-processing.
Regardless of the task paradigm, reaction times on trials after
performance errors are usually longer than reaction times on
trials following correct responses, a process referred to as
post-error slowing. Reaction times, the number of errors and
this post-error slowing are all regarded as behavioural in-
dices of error monitoring.42,43
Event-related potential measures of error processing
Event-related potential investigations of error processing have
revealed 2 error-related brain waves that consistently emerge
after performance errors (i.e., error-related negativity [ERN]
and error positivity [Pe]). The ERN and Pe appear to be in -
dependent as they are differentially sensitive to experimental
manipulations and individual differences in task perform -
ance, and they reflect different stages of error processing.40,44,45
The ERN arises 50–80 ms after making an error and is known
to reflect initial and automatic error detection.46 Converging
evidence indicates that the ACC is the neural generator of the
ERN.8,47–50 The ERN is followed by the Pe, a positive deflection
observed on the electroencephalogram (EEG), emerging ap-
proximately 300 ms after incorrect responses.51 Research iden-
tifying the neural origin of the Pe has provided heterogeneous
results.52 Conceptually, the Pe appears to be associated with
the more conscious evaluation of errors, error awareness,40,52
and with the motivational significance attributed to an error.53
Together, the ERN and Pe evaluate the correctness of ongoing
behaviour (i.e., a specific outcome or behaviour was worse or
better than expected), which is used to guide future behav-
iour54 and can be used as a neural marker of error processing
in individuals with addictions.
Functional MRI measures of error processing
The crucial role for the ACC in error processing suggested by
ERP studies has been confirmed in fMRI studies. More
specifically, Ridderinkhof and colleagues24 suggest that the
dACC/pre-SMA, is consistently activated during monitoring
of ongoing behaviour. Some researchers suggest that this re-
gion monitors response conflict or the likelihood of errors55,56
rather than error processing per se. Two independent meta-
analyses have shown that both response conflict and re-
sponse error activate the dACC.8,57 Functional MRI studies in-
vestigating error processing further show that a large neural
network coactivates with the dACC, including the bilateral
insula, DLPFC, thalamus and right IPL.57,58 Functional interac-
tions among these regions have been reported, especially be-
tween the dACC and the DLPFC.59 Performance errors in the
human brain are processed by a neural circuit that extends
beyond the dACC and includes the insula, DLPFC, thalamus
and parietal regions. This error processing circuit collectively
monitors and adjusts behaviour when necessary. As the
neuro anatomical substrate of error processing has consist -
ently been demonstrated in fMRI studies in healthy partici-
pants, activation differences between individuals with addic-
tions and controls in this error processing network may be
interpreted as a neural correlate of possible error-related
deficits in individuals with addictions.
Literature review
Selection of studies
We performed a literature search on PubMed and Embase
 using search medical subject headings (MeSH) for substance-
dependent populations and populations with possible behav-
ioural addictions. The MeSH terms were “substance-related
disorders,” “alcohol-related disorders,” “amphetmine-related
disorders,” “cocaine-related disorders,” “marijuana abuse,”
“opioid-related disorders,” “gambling,” “obesity,” “bulimia”
and “eating disorders.” We also searched using the keywords
“smokers,” “gaming,” “gamers” and “Internet.” The key
search terms for various addicted populations had to co-occur
in combination with the following search terms concerning in-
hibitory control and error processing: “cognitive control,” “in-
hibitory control,” “response inhibition,” “error processing,”
“error monitoring,” “go/no-go,” “stop-signal” or “Flanker.”
They also had to co-occur in combination with the following
search terms for neuroimaging measures: “magnetic resonance
imaging,” “evoked potentials” (MeSH terms), “error-related
negativity,” “error positivity,” “N200,” “N2,” “P300” and
“P3.” The search was limited to research performed in humans
and articles written in English. All included articles were re-
quired to be published in peer-reviewed journals and indexed
in PubMed or Embase before June 2013. 
We screened a total of 207 abstracts for the following inclu-
sion criteria: inclusion of a group of individuals with addic-
tions or individuals showing behavioural addictions (social
drinkers and recreational drug users were not included); in-
clusion of a control group such that hypoactivation or hyper-
activation as well as behavioural deficits described in this re-
view are always relative to healthy controls (studies without
a control group were included only if they evaluated the ef-
fect of a treatment outcome or a pharmacological interven-
tion within the addiction group); inclusion of more than
10 participants in each group; us of the go/no-go, stop- signal
or Eriksen Flanker task as a measure for inhibitory control or
error processing; and the use of fMRI or ERPs as neuroim -
aging tools. A total of 36 studies fulfilled our inclusion crite-
ria. We manually searched the references in those 36 articles,
which yielded another 5 studies that met our inclusion cri -
teria. In all, we included 41 studies in our review. Table 1,
displays all relevant participant characteristics, such as age,
sex, abstinence, disorder and treatment status. Results of all
studies are summarized in Tables 2 and 3, and are discussed
in the sections that follow. We refer to the tables for study de-
tails, such as participant characteristics and within-subject
contrasts, that were used for between-subject analyses in our
discussion of these results.
Inhibitory control
Inhibitory control in individuals with nicotine dependence
We identified 2 ERP studies in the domain of inhibitory con-
trol in individuals with nicotine dependence. Evans and col-
leagues60 investigated inhibitory control in participants with
nicotine dependence (abstinence 0–10.5 h) and controls by
evaluating P3 (but not N2) amplitudes in a go/no-go task.
While no-go P3 amplitudes were lower in those with nicotine
dependence than controls, no performance differences be-
tween the groups were found. Luijten and colleagues61 inves-
tigated whether inhibitory control in nicotine-dependent in-
dividuals who had abstained from smoking for 1 hour was
influenced by the presence of smoking cues. Compared with
controls, those with nicotine dependence were less accurate
on no-go tasks and exhibited lower no-go N2 amplitudes.
The P3 amplitudes did not differ between groups. Interest-
ingly, behavioural deficits as well as lower N2 amplitudes in
individuals with nicotine dependence were found during ex-
posure to both smoking-related and neutral pictures, sug-
gesting that the observed deficit in inhibitory control reflects
a general inhibition problem that is not further impaired
when smoking cues are present.
We also included 5 fMRI studies of inhibitory control in
smokers. One of the key regions involved in inhibitory con-
trol, the dACC, was less active in individuals with nicotine
dependence than controls during performance of the stop-
signal task, while SSRTs did not differ.62 Using a go/no-go
task, Nestor and colleagues63 found behavioural deficits for
inhibitory control in nonabstinent individuals with nicotine
dependence compared with both healthy controls and ex-
smokers who were smoke-free for at least 1 year. In addition,
the finding of lower brain activation associated with in-
hibitory control in those with nicotine dependence compared
with controls in the ACC was confirmed in this study and ex-
tended to the right superior frontal gyrus (SFG), left middle
frontal gyrus (MFG), bilateral IPL and middle temporal
gyrus (MTG). The nicotine-dependent and ex-smokers
groups both showed less activation in the left IFG, bilateral
insula, paracentral gyrus, right MTG and left parahippocam-
pal gyrus (PHG) than controls. These results suggest that be-
havioural and activation deficits in individuals with nicotine
dependence may be reversible to some extent, while hypo -
activation in other regions persists even after prolonged per -
iods of abstinence. An alternative interpretation may be that
in heavily dependent smokers there is an association between
the more pronounced behavioural and neural deficits and the
failure to give up smoking. The findings of a study involving
adolescents with nicotine dependence who abstained from
smoking for 30–1050 minutes before scanning support this
hypothesis.64 While adolescents with nicotine dependence
and controls had similar accuracy rates and brain activation,
the study found that severity of smoking within those with
nicotine dependence was associated with lower activation in
regions critically involved in inhibitory control (i.e., ACC,
SMA, left IFG, left orbitofrontal cortex [OFC], bilateral MFG
and right SFG).
The pharmacology of inhibitory control in individuals with
nicotine dependence and controls was investigated in an
fMRI study using a double-blind randomized crossover de-
sign with placebo and the dopamine antagonist haloperidol.65
The nicotine-dependent individuals did not smoke for at least
4 hours before the go/no-go task performance. Behavioural
findings showed lower no-go accuracy during the first test as
well as hypoactivation in the right ACC and MFG and the left
IFG after placebo in individuals with nicotine dependence
compared with controls. Hyperactivation in participants with
nicotine dependence after placebo was found in the right TPJ,
which may constitute an attentional compensation mechan -
ism.18 After administration of haloperidol, hypoactivation in
those with nicotine dependence relative to controls was found
only in the right ACC but no longer in the right MFG and left
IFG. Activation patterns suggest that similar brain activation
for individuals with nicotine dependence and controls after
administration of haloperidol is most likely due to a reduction
in brain activation in controls caused by haloperidol. These
findings suggest that reduced dopaminergic neurotransmis-
sion may be disadvantageous for inhibitory control, which
was further supported by the findings that no-go accuracy
rates as well as brain activation in the inhibitory control net-
work (i.e., the left ACC, right SFG, left IFG, left posterior cin-
gulate gyrus [PCC] and MTG) were reduced across groups af-
ter haloperidol administration compared with placebo. These
findings provide valuable information regarding the role of
Luijten et al.
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dopaminergic neurotransmission on inhibitory control and
suggest that altered baseline dopamine levels in individuals
with addictions may contribute to problems with inhibitory
control in these individuals.
Berkman and colleagues66 investigated the link between
brain activation during inhibitory control on a go/no-go task
and real world inhibition of craving. Individuals with nicotine
dependence reported cravings and number of smoked ciga-
rettes several times during the first 3 weeks after a quit at-
tempt. The study found that higher brain activation associated
with inhibitory control in the bilateral IFG, SMA, putamen and
left caudate attenuated the association between craving and
Table 1: Patient characteristics of included studies (part 1 of 2) 
Study Mean age (SD) Sex Abstinence Race Disorder status Treatment status 
Nicotine dependence 
Berkman et al.66
(2011) 
27 ND: 46 (9.7) ND: 50% male — ND: 19% AA, 52% 
W, 26% HP 
≥ 10 cigarettes/d 
for ≥ 1 yr 
In cessation 
program 
Evans et al.60
(2009) 
49 ND: 29.9 (9.9) 
22 HC: 25.0 (7.2) 
ND: 49% male 
HC: 41% male 
No abstinence required 
for half of smokers. Other 
half minimal 10.5 h 
ND: 92% W 
HC: 95% W 
≥ 15 cigarettes/d 
for ≥ 1 yr 
No intention to quit 
de Ruiter et al.62 
(2012)* 
18 ND: 33.8 (9.1) 
17 HC: 34.7 (9.7) 
ND: 100% male 
HC: 100% male 
— — ≥ 15 cigarettes/d No intention to quit 
Franken100 (2010) 21 ND: 21.7 (2.7) 
25 HC: 21.3 (2.8) 
ND: 52% male 
HC: 44% male 
—h1tsaeltA ≥ 5 cigarettes/d for 
≥ 1 yr 
No intention to quit 
Galván et al.64
(2011) 
25 ND: 19.3 (1.6)  
25 HC: 19.0 (1.3) 
ND: 60% male 
HC: 56% male 
30–1050 min ND: 20% W, 4% AA, 
20% HP, 32% AZ 
HC: 12% W, 16% 
AA, 4% HP, 36% AZ 
Daily smoking 
≥ 6 mo 
No intention to quit 
Luijten et al.61
(2011) 
19 ND: 21.4 (2.0) 
20 HC: 21.6 (2.2) 
ND: 74% male 
HC: 70% male 
—h1tsaeltA ≥ 10 cigarettes/d 
for ≥ 2 yr 
No intention to quit 
Luijten et al.101 
(2011) 
13 ND: 20.7 (1.3)  
14 HC: 21.4 (2.6) 
ND: 69% male 
HC: 71% male 
—h1tsaeltA ≥ 10 cigarettes/d 
for ≥ 2 yr 
No intention to quit 
Luijten et al.65
(in press) 
25 ND: 22.6 (2.8) 
23 HC: 21.7 (1.8) 
ND: 72% male 
HC: 61% male 
—h4tsaeltA ≥ 15 cigarettes/d 
for ≥ 2 yr 
No  intention to quit 
Nestor et al.63
(2011) 
13 ND: 24.3 (1.2) 
10 ex-ND: 25.4 (1.6)
13 HC: 23.6 (1.3) 
ND: 54% male 
ex-ND: 30% 
male  
HC: 38% male 
ND: No abstinence 
requirements 
ex-ND: at least 1 yr 
M = 84.8 (13.6) wk 
— ND: ≥ 10 cigarettes/d 
for ≥ 2 yr  
ex-ND met this 
requirement prior to 
abstinence 
ND: No intention to 
quit 
Alcohol dependence 
Cohen et al.68
(1997) 
17 AD: 36.1 (6.1) 
30 HC: 25.9 (5.9) 
AD: 100% male 
HC: 100% male 
—d82 No diagnoses 
assessed 
21.3 (9.3) d/mo 
11.7 (5.4) drinks 
per occasion 
Inpatient treatment 
Colrain et al.69
(2011) 
10 AD: 53.1 (9.1) 
25 HC: 56.5 (12.8) 
AD: 50% male 
HC: 48% male 
M = 1 yr (2 d–2.5 yr)  DSM IV diagnosis 
abuse/dependence 
Outpatient 
treatment 
Fallgatter et al.72
(1998) 
20 AD: 44.1 (9.1) 
20 HC: 40.8 (11.1) 
AD: 80% male 
HC: 80% male 
—d01 DSM IV diagnosis 
dependence 
Inpatient treatment 
Kamarajan et al.67
(2005) 
30 AD: 34.3 (4.7) 
30 HC: 24.1 (5.5) 
AD: 53% male 
HC: n/m 
Abstinent;  duration 
n/m 
— DSM IV diagnosis 
dependence 
In treatment 
Karch et al.71,74 
(2007, 2008)† 
16 AD:41.6 (7.5) 
16 HC: 39.3 (8.0) 
AD: 100% male 
HC: 100% male 
—d)5.7(6.21 ICD-10 10.2 
diagnoses 
Inpatient treatment 
Li et al.75 (2009) 24 AD: 38.7 (8.3) 
24 HC: 35.7 (5.9) 
AD: 75% male 
HC: 75% male 
11–17 d AD: 29 % AA, 71% W
HC: 21% AA, 79% W
DSM IV diagnosis 
dependence 
Inpatient  treatment 
Padilla et al.102 
(2011) 
14 AD: 37.9 (9.3) 
14 HC: 43.5 (14.5) 
AD: 100% male 
HC: 100% male 
71.91 (32.9) d — DSM IV diagnosis 
dependence 
n/m 
Pandey et al.73
(2012) 
78 AD: 40.7 (SE 0.7) 
58 HC: 21.1 (SE 0.3) 
AD: 100% male 
HC: 100% male 
—d03 DSM IV diagnosis 
dependence 
Inpatient treatment 
Pfefferbaum et al.70
(1987) 
42 AD: 26-62 
66 HC: n/m 
—d36–11m/n DSM III diagnosis 
dependence 
Inpatient treatment 
Schellekens et al.103
(2010) 
8 AD ANX+: 47 (8.5)
21 AD:43 (4.9) 
15 HC: 44 (8.7) 
AD: 100% male 
HC: 100% male 
—om1 DSM IV diagnosis 
dependence 
Inpatient  treatment 
Schmaal et al.76
(2013)  
16 AD: 42.9 (9.4) 
16 HC: 41.7 (8.2) 
AD: 100% male 
HC: 100% male 
At least 2 wk — DSM IV diagnosis 
dependence 
In treatment 
Cannabis dependence 
Hester et al.81
(2009) 
16 CaD: 24.6 (1.5) 
16 HC: 25.2 (1.3) 
CaD: 94% male 
HC: 94% male 
38.0 (47.7) h — ≥ 5 d/wk for ≥ 2 yr 
and 500 lifetime 
occasions 
Not in treatment 
Luijten et al.
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Table 1: Patient characteristics of included studies (part 2 of 2) 
Study Mean age (SD) Sex Abstinence Race Disorder status Treatment status 
Cannabis dependence (cont’d) 
Tapert et al.82
(2007) 
16 CaD: 18.1 (0.7) 
17 HC: 17.9 (1.0) 
CaD: 75% male 
HC: 71% male 
58.4 (52.8) d 
At least 28 d 
CaD: 75% W 
HC: 59% W 
DSM IV diagnosis 
dependence or ≥ 60 
lifetime occasions  
Not in treatment 
Stimulant dependence
Franken et al.7
(2007) 
14 CoD: 38.1 (10.2) 
13 HC: 32.0 (13.8) 
CoD: 93% male 
HC: 62% male 
At least 1 mo (1–13) — DSM IV diagnoses 
dependence 
Inpatient treatment 
Hester et al.57 
(2004) 
15 CoD: 40 (22–48) 
15 HC: 31 (20–40) 
CoD: 60% male 
HC: 47% male 
M = 41 (12–72) h — Weekly users 
M = 5 d/wk 
Not in treatment 
Kaufman et al.87 
(2003) 
13 CoD: 37 (4.5) 
14 HC: 30 (8.7) 
CoD: 62% male 
HC: 29% male 
—h27–81 Long term users 
11–22 yr of use 
Not in treatment 
Leland et al.91
(2008)  
17 MD: 40.4 (9.9) 
19 HC: 40.3 (8.1) 
MD: 89% male 
HC: 84% male 
33.9 (5.9, 25–50) d MD: 72% W 
HC: 53% W 
DSM IV diagnoses 
dependence 
Inpatient treatment  
Li et al.88 (2008) 15 CoD: 37.7 (6.8)  
15 HC: 36.6 (6.0) 
CoD: 100% male
HC: 100% male 
At least 2 wk CoD: 26.7% AA,  
73.3 W 
HC: 26.7% AA,  
53.3 W, 20% HP 
DSM IV diagnoses 
dependence 
Inpatient treatment  
Li et al.90 (2010) 10 CoD: 39. 9 (5.5) CoD: 80% male At least 5 d (M = 7.6) — DSM IV diagnoses 
dependence 
Inpatient treatment  
Luo et al.89 (2013) 97 CoD: 39.8 (7.5) CoD: 62% male 2–4 wk CoD: 67% AA, 
29% W 
DSM IV diagnoses 
dependence 
Inpatient treatment  
Marhe et al.105 
(2013) 
49 CoD: 39.6 (8.4) 
23 HC: 39.9 (9.4) 
CoD: 89% male 
HC: 74% male 
—h27tsaeltA DSM IV diagnoses 
dependence 
Inpatient treatment  
Sokhadze et al.85
(2008) 
19 CoD: 42.1 (5.5)  
15 HC: 37.0 (9.4) 
CoD: 63% male 
HC: 67% male 
No requirements  
Active users 
CoDi: 40% AA 
HC: — 
DSM IV diagnosis 
abuse/dependence 
Not in treatment 
Opiate dependence 
Forman et al.106
(2004) 
13 OD: 35.3 (10.2) 
13 HC: 34.9 (9.3) 
OD: 46% male 
HC: 46% male 
M = 15.5 (0–21) d OD: 15% AA, 85% W
HC: 15% AA, 85% W
DSM IV diagnoses 
dependence 
In treatment  
Fu et al.93 (2008) 30 OD: 33.4 (6.0)  
18 HC: 29.6 (6.9) 
OD: 100% male 
HC: 100% male 
M = 7.6 (2.2, 4–11) wk — DSM IV diagnoses 
dependence 
Inpatient treatment 
Yang et al.92 (2009) 14 OD: 41 (7.1) 
14 HC: 41 (10.5) 
OD: 100% male 
HC: 100% male 
M = 4.7 (6.4) mo — DSM IV diagnosis 
abuse/dependence 
In treatment  
Behavioural addictions 
de Ruiter et al.62 
(2012)* 
18 PG: 35.3 (9.4) 
17 HC: 34.7 (9.7) 
PG: 100% male 
HC: 100% male 
— — 82 % DSM IV 
diagnoses patho-
logical gambling 
In treatment 
Dong et al.95 (2010) 12 EIU: 20.5 (4.1) 
12 HC: 20.2 (4.5) 
EIU: 100% male
HC: 100% male 
— — Young’s IAT score 
≥ 7 
Not in treatment 
Hendrick et al.98
(2012) 
13 OB: 34.8 (9.6) 
18 HC: 26.2 (6.7) 
OB: 0% male 
HC: 0% male 
No abstinence required — BMI ≥ 30 Not in treatment 
Littel et al.96 (2012) 25 EG: 20.5 (3.0) 
27 HC: 21.4 (2.6) 
EG: 92% male 
HC: 37% male 
— — VAT score ≥ 2.5 Not in treatment 
Lock et al.99 (2011) 13 BE: 17.3 (1.2) 
13 HC: 15.9 (1.4) 
BE: 0% male 
HC: 0% male 
— BE: 69% W, 15% 
AZ 
HC: 77% W, 15% 
AZ 
DSM IV diagnoses 
bulimia nervosa or 
anorexia nervosa 
type binge 
eating/purging 
Outpatient 
treatment 
van Holst et al.97
(2012) 
16 PG: 34.4 (11.1)  
15 HC: 36.2 (10.7) 
PG: 100% male 
PG: 100% male 
— n/m 94% DSM IV 
diagnoses 
pathological 
gambling 
In treatment 
Zhou et al.94 (2010) 26 EIU: 25 (6) 
26 HC 25 (6) 
EIU: 73% male
HC: 73% male 
— EIU: 100% AZ 
HC: 100% AZ 
Met the criteria of 
the modified 
Young’s IAT 
In treatment 
AA = African American; AD = alcohol dependence; ANX+ = anxious; AZ = Asian; BE = binge eaters; BMI = body mass index; CaD = cannabis dependence; CoD = cocaine dependence; 
EG = excessive gaming; EIU = excessive Internet use; HC = healthy controls; HP = Hispanic; IAT = Internet addiction test; MD = methamphetamine dependence; ND = nicotine 
dependence; OB = obese; OD = opiate dependence; PG = pathological gambling; SD = standard deviation; SE = standard error; VAT = video game addiction test; W = white. 
*Include an ND, PG and HC group and therefore is included in ND and behavioural addiction sections.  
†Include exactly the same participants and are therefore summarized together. 
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Table 2: Overview of ERP and fMRI studies investigating inhibitory control in substance dependence and behavioural addictions (part 1 of 3) 
 Study Participants Measures Main results, behaviou  gnigami ,stluser niaM lar
Nicotine dependence   
Evans et al.60 
(2009) 
49 ND 
22 HC 
ERPs 
Go/no-go task 
No group differences N2: not investigated 
P3 no-go – go: ND < HC in central and parietal clusters 
Luijten et al.61 
(2011) 
 
19 ND 
20 HC 
ERPs 
Go/no-go task with 
smoking and neutral 
pictures 
ACCU: NCI < HC No-go N2: ND < HC for both smoking and neutral pictures at 
frontocentral cluster 
Go N2: no group differences 
Go and no-go P3: no group differences 
Berkman et al.66 
(2011) 
 
27 ND fMRI 
Go/no-go task 
Not applicable Contrast: no-go C – go 
The higher the activation in bil-IFG, bil-SMA, bil-putamen and l-caudate, 
the lower the correlation between craving and smoking after a quit 
attempt. This moderation effect was opposite for r-amygdala 
de Ruiter et al.62  
(2012)*‡ 
18 ND 
17 HC 
fMRI 
Stop-signal task 
No group differences Contrast: stop C – control 
ND < HC: r-dACC 
Galván et al.64 
(2011) 
25 ND  
25 ND 
fMRI 
Stop-signal task 
No group differences Contrast: stop C – go 
No group differences  
Neg corr within ND group with heaviness of smoking in  
bil-MFG, ACC, SMA, l-OFC, r-SFG, l-IFG 
Luijten et al.65 
(2013) 
25 ND 
23 HC 
fMRI 
Go/no-go task 
After PL and single 
dose of HAL 
ACCU: ND < HC on 
first test occasion 
HAL < PL 
RT: ND > HC 
 
 
Contrast no-go C – go C 
ND < HC after PL and HAL: r-ACC 
ND < HC after PL: r-MFG, l-IFG 
ND > HC after PL: r-TPJ 
ND < HC after HAL: r-PCC 
HAL < PL in ND and HC: l-ACC, r-SFG, l-IFG, l-PCC, l-MTG 
HA < PL in HC: l-IFG 
HA < PL in ND: r-PCC 
Alcohol dependence 
Nestor et al.63 
(2011)* 
13 ND 
10 ex-ND 
13 HC 
 
fMRI  
Go/no-go task 
RTs:  
ND & HC < ex-ND 
ACCU:  
ND < ex-ND & HC 
Contrast: no-go C v. baseline 
ND < HC: r-SFG, l-MFG, r-ACC, bil-IPL 
ND & ex-ND < HC: l-IFG, bil-PCG, r-STG, r-MTG, bil-insula, l-PHG 
ND < ex-ND & HC: l-MTG 
ND < ex-ND: l-ACC 
Cohen et al.68 
(1997) 
17 AD 
30 HC 
ERPs 
Go/no-go task with 
selection of response 
hand 
RTs AD > HC N2: not investigated 
No-go P3: AD < HC, whole brain  
Go P3: AD < HC, whole brain 
Go v. no-go P3: not different in AD. In HC go > no-go in central, 
parietal and temporal clusters. 
Colrain et al.69 
(2011) 
10 AD 
25 HC 
ERPs 
Combined oddball and 
go/no-go task 
No behavioural data 
reported 
N2: not investigated 
No-go P3: AD < HC at CZ 
Go P3: no group differences 
Fallgatter et al.72 
(1998) 
20 AD 
20 HC 
ERPs 
Go/no-go task with 
warning cues 
No group differences N2: not investigated 
P3: location of go P3 more posterior in AD. The more anterior the no-go 
P3, the lower the sensation seeking score in AD 
Kamarajan et 
al.67 (2005) 
30 AD 
30 HC 
ERPs 
Go/no-go task with 
reward properties 
ACCU: AD < HC  N2: not investigated 
No-go P3: AD < HC in frontal and central clusters.  
Go P3: AD < HC for go in parietal cluster 
Go versus no-go P3: go > no-go in parietal and occipital clusters 
Karch et al.71 
(2007)† 
16 AD 
8 ANX+, 8 
ANX–, 16 HC 
ERPs 
Go/no-go task with 
warning cues 
No group differences N2: not investigated 
P3: no group differences 
No differences between ANX+ and ANX- 
Pandey et al.73 
(2012) 
78 AD 
58 HC 
ERPs 
Go/no-go task 
RTs: AD>HC 
ACCU GO: 
AD < HC 
Go N2: AD < HC at frontal and central clusters 
No-go N2: AD < HC at frontal, central, parietal and temporal clusters 
No-go > go N2; AD:  central, parietal, occipital and temporal clusters 
No-go > go N2; HC: frontal, parietal, occipital and temporal clusters 
P3: not investigated 
Pfefferbaum et 
al.70 (1987) 
 
42 AD 
66 HC 
ERPs 
Go/no-go task with 
varying probabilities 
No group differences N2: not investigated 
No-go P3: no group differences 
Go P3: AD < HC at CZ and PZ  
Karch et al.74 
(2008)† 
16 AD 
8 ANX+, 8 
ANX–, 16 HC 
fMRI 
Go/no-go task with 
warning cues 
 
No group differences Contrast: no-go v. baseline  
No group differences 
ANX+ > ANX-: l-MFG, bil-SFG, bil-MTG, r-IFG, bil-IPL,  
bil-precuneus, r-PCC, l-thalamus 
ANX+ < ANX-: r-SFG, r-PCG, l-STG, bil-IPL 
Li et al.75 
(2009)* 
24 AD 
24 HC 
fMRI 
Stop-signal task 
RTs: AD > HC 
ACCU: AD > HC 
Contrast: stop C – stop E 
AD < HC: l-DLPFC 
Luijten et al.
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Table 2: Overview of ERP and fMRI studies investigating inhibitory control in substance dependence and behavioural addictions (part 2 of 3) 
 Study Participants Measures Main results, behaviou  gnigami ,stluser niaM lar
Alcohol dependence (cont’d)   
Schmaal et al.76 
(2013)  
16 AD 
16 HC 
fMRI 
Stop-signal task 
After PL and single dose 
of MF 
No group differences or main effect of 
MF 
Pos corr baseline SSRT and 
improvement in SSRT after MF 
Contrast: stop C – stop E 
In AD and not in HC: MF > PL: l-putamen 
In AD and not in HC: pos corr MF > PL with improvement 
SSRT after MF: l-SMA, r-ventrolateral thalamus  
Cannabis dependence 
Hester et al.81 
(2009)* 
16 CaD 
16 HC 
fMRI 
Go/no-go task 
No group differences Contrast: no-go C v. baseline 
CaD > HC: r-IPL, r-putamen, r-pre-SMA 
Tapert et al.82 
(2007) 
 
16 CaD  
17 HC 
fMRI  
Go/no-go task 
No group differences Contrast: no-go v. baseline  
CaD > HC: bil-SFG, bil-MFG, r-insula, bil-medFG, bil-
IPL, bil-SPL, r-lingual, r-MOG 
Contrast: go v. baseline 
CaD > HC: r-IFG, r-insula, r-SFG, r-SPL , r-IPL, r-
precuneus 
Stimulant dependence   
Sokhadze et al.85 
(2008)* 
19 CoD  
15 HC 
ERPS 
Combined flanker and 
go/no-go task 
RTs: CoD > HC 
ACCU: CoD < HC in the congruent 
flanker condition 
N2 no-go – go: CoD < HC for incongruent trials at 
frontal cluster 
P3 no-go – go: CoD < HC at frontal cluster 
Hester and 
Garavan86 
(2004) 
15 CoD  
15 HC 
fMRI 
Go/no-go task with 
varying WM demands 
ACCU: CoD < HC Contrast: no-go C v. baseline 
CoD < HC: r-SFG, r-pre-SMA, l-ACC 
Kaufman et al.87  
(2003)* 
13 CoD  
14 HC 
fMRI  
Go/no-go task 
ACCU: CoD < HC Contrast: no-go C v. baseline 
CoD < HC: r-dACC, r-insula 
Leland et al.91 
(2008)  
 
17 MD 
19 HC 
fMRI  
Go/no-go task with 
warning cues 
ACCU after warning > ACCU without 
warning in CoD and not in HC 
Contrast: no-go C – go 
No group differences  
Contrast: warning go cues > go cues 
MD > HC: vACC, dACC 
Li et al.88 (2008) 15 CoD  
15 HC 
fMRI 
Stop-signal task 
No group differences Contrast: stop C – stop E 
CoD < HC: ACC, r-SPL, l-SPL, l-IOG 
Li et al.90 (2010) 10 CoD  
 
fMRI 
Stop-signal task 
After placebo and single 
dose of MP 
SSRT MP < PL Contrast: stop C – stop E 
MP > PL: bil-striatum, bil-thalamus, r-cerebellum 
PL < MP: r-STG 
SSRT MP < SSRT PL 
pos corr: l-MFG,  
neg corr: r-VMPFC 
Luo et al.89 
(2013) 
97 CoD fMRI 
Stop-signal task 
SSRT not predictive for relapse  Contrast: stop C – stop E 
Relapsers < nonrelapsers: none 
Relapsers > nonrelapsers: none 
Opiate dependence   
Yang et al.92 
(2009) 
14 OD 
14 HC 
ERPs 
Go/no-go task 
No group differences No-go N2: no group differences 
Go N2: OD > HC at midline cluster 
P3: no group differences 
Fu et al.93 
(2008) 
30 OD 
18 HC 
fMRI 
Blocked go/no-go task 
RTs: OD > HC Contrast: go/no-go block – go block 
OD < HC: bil-medPFC, bil-ACC, bil-IFG, l-MFG, l-
insula, l-uncus, l-PHG, r-precuneus, r-SPL, r-MTG 
Behavioural addictions   
Dong et al.95 
(2010) 
 
12 EIU 
12 HC 
ERPs 
Go/no-go task 
No group differences No-go N2: EIU < HC at frontal, central and parietal 
clusters 
Go N2: no group differences 
No-go P3: EIU > HC at frontal, central and parietal 
clusters 
Go P3: no group differences 
Littel et al.96 
(2012)* 
25 EG 
27 HC 
ERPs 
Go/no-go task 
ACCU: EG < HC 
Go RTs: EG < HC 
No-go N2: EG > HC at a parietal cluster 
Go N2: no group differences 
No-go P3: no group differences 
Go P3: no group differences 
Zhou et al.94  
(2010) 
 
26 EIU 
26 HC 
ERPs 
Go/no-go task with 
reward properties 
ACCU: EIU < HC No-go N2: EIU < HC at frontal and central clusters.  
Go N2: not analyzed 
P3: not investigated 
de Ruiter et al.62  
(2012)*‡ 
18 PG 
17 HC 
fMRI 
Stop-signal task 
No group differences Contrast: stop C – control 
PG < HC: r-dACC 
Hendrick et al.98 
(2012) 
13 OB 
18 HC 
fMRI 
Stop-signal task 
No group differences Contrast: stop C and E – go C 
Obese < HC: bil-IPL, bil-insula, r-occ, l-IFG, bil-
cuneus, r-SFG, bil medFG, l-MTG 
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real world smoking, while an association in the opposite direc-
tion was found for the amygdala. Two important conclusions
can be drawn from this study. First, brain activation in an ab-
stract laboratory task to measure inhibitory control is associ-
ated with inhibition of feelings of craving in daily life. Second,
lower brain activation in regions critical for inhibitory control
is actually disadvantageous because it is associated with a
strong coupling between craving and smoking.
Summary: The 2 ERP studies provide tentative evidence that
N2 amplitudes may be lower in individuals with nicotine de-
pendence than controls, while results for P3 amplitudes are
contradictory. Functional MRI studies show hypoactivation
in the inhibitory neural network that may be associated with
severity of smoking and could be partly reversible after
smoking cessation. Hypoactivation during inhibitory control
has been shown to be disadvantageous for smoking behav-
iour, as it was associated with increased coupling between
craving and smoking after a quit attempt. Notably, hypoacti-
vation associated with inhibitory control in individuals with
nicotine dependence was not always accompanied by behav-
ioural deficits, thereby complicating the interpretation of
some of the observed findings. Furthermore, dopaminergic
modulation appears to influence inhibitory control capacities.
Inhibitory control in individuals with alcohol dependence
All studies included in this section involve abstaining indi-
viduals with alcohol dependence who were currently enrol -
led in treatment programs. We identified 7 ERP studies for
inclusion in this section, 6 of which evaluated P3 amplitudes
related to inhibitory control. Kamarajan and colleagues67
found that individuals with alcohol dependence were less
 accurate than controls during task performance, whereas the
other studies did not observe accuracy differences between
in dividuals with alcohol dependence and controls. In 3 stud-
ies, smaller no-go P3 amplitudes were observed in individu-
als with alcohol dependence compared with controls.67–69
However, some of these and other studies also found less
pronounced P3 amplitudes for go trials,67,68,70 suggesting that
group differences in these studies do not merely reflect dif-
ferences in inhibitory capacities but rather may be related to
more general deficits (e.g., attention). In contrast, Karch and
colleagues71 and Fallgatter and colleagues72 did not find
deficits in individuals with alcohol dependence on either go
or no-go P3 amplitudes. Comparison of these studies is ham-
pered by considerable methodological differences. First, task
paradigms differed greatly among studies: in some studies
go and no-go probabilities varied across blocks70 or no-go
probabilities were high, resulting in low inhibitory require-
ments.67,72 In addition, some task paradigms involved reward
evaluation67 or cueing for no-go trials.72 Second, data analyses
in some studies were not focused on regions in which no-go
amplitudes usually peak68 or were focused on P3 localization
rather than amplitudes.72 Altogether, evidence for neural
deficits in the later stages of inhibitory control in individuals
with alcohol dependence is mixed, most likely as a result of
large methodological differences. One of the included ERP
studies investigated N2 amplitudes in participants with alco-
hol dependence.73 In this study, no behavioural deficits were
found for no-go accuracy, while participants with alcohol
 dependence were less accurate on go trials and showed
lower go and no-go N2 amplitudes compared with controls.
We identified 3 fMRI studies for inclusion in this section.
Notably, as brain activation was simultaneously measured
with EEG and fMRI, the fMRI study by Karch and col-
leagues74 involves the same patients as the described ERP
study by the same group.71 The fMRI findings in these pa-
tients confirm ERP findings of comparable brain activation
Table 2: Overview of ERP and fMRI studies investigating inhibitory control in substance dependence and behavioural addictions (part 3 of 3) 
 Study Participants Measures Main results, behavioural Main results, imaging 
Behavioural addictions (cont’d)   
Lock et al.99 
(2011) 
13 BE 
13 HC 
fMRI 
Go/no-go task 
No group differences Contrast: no-go C – go C 
BE > HC: r-DLPFC, r-ACC, r-MTG, bil-
precentral gyri, bil-hypothalamus 
van Holst et al.97 
(2012) 
16 PG 
15 HC 
fMRI 
Go/no-go task with gambling, neutral, 
negative and positive pictures  
ACCU: PG > HC during 
gambling block 
Go RT’s: PG > HC 
Contrast no-go neutral – go C 
PG > HC: bil-DLPFC, r-ACC 
Contrast no-go gambling – no-go neutral 
PG < HC: bil-DLPFC, r-ACC 
Contrast no-go positive – no-go neutral 
PG < HC: bil-DLPFC, l-VS 
Contrast no-go negative – no-go neutral 
PG < HC: r-DLPFC, l-ACC 
ACC = anterior cingulate cortex; ACCU = accuracy; AD = alcohol dependence; ANX+ = high levels of anxiety; ANX- = low levels of anxiety; BE = binge eating; bil- = bilateral; CaD = 
cannabis dependence; CoD = cocaine dependence;  dACC = dorsal anterior cingulate cortex; DLPFC = dorsolateral prefrontal cortex; EG = excessive gaming; EIU = excessive Internet 
use; ERP = event-related potentials; fMRI = functional magnetic resonance imaging; HAL = haloperidol; HC = healthy control; IFG = inferior frontal gyrus; IOG = inferior occipital gyrus; 
IPL = inferior parietal lobe; l- = left; MD = methamphetamine dependence; MF = modafinil; MFG = middle frontal gyrus; MTG = middle temporal gyrus; MOG = middle occipital gyrus;  
MP = methylphenidate; ND = nicotine dependence; neg corr = negative correlation; no-go C = no-go correct; OB = obese patients; OD = opiate dependence; OFC = orbitofrontal gyrus; 
PG = pathological gamblers; PCC = posterior cingulate gyrus; PCG = postcentral gyrus; PG = pathological gambling; PHG = parahippocampal gyrus; PL = placebo; pos corr = positive 
correlation; r- = right; RT = reaction time; SFG = superior frontal gyrus; SMA = supplementary motor area; SPL = superior parietal lobe; SSRT = stop signal reaction time; stop C = no-go 
correct; stop E = no-go error; vACC = ventral anterior cingulate cortex; VMPFC = ventromedial prefrontal cortex; VS = ventral striatum. 
*Study is also included in the error processing section. 
†These papers are based on data from the same participants.  
‡This study includes a ND, PG and HC group and therefore is included in ND and behavioural addiction sections.  
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Table 3: Overview of ERP and fMRI studies investigating error processing in substance dependence and behavioural addictions 
Study Participants Measures Main results, behaviour gnigami,stluserniaMla
Nicotine dependence 
Franken et al.100
(2010) 
21 ND 
25 HC 
ERPs 
Flanker task 
No group differences ERN: no group differences 
Pe error: ND < HC at Fz, Cz, Pz  
Pe correct: no group differences 
Luijten et al.101 
(2011) 
13 ND 
14 HC 
ERPs 
Flanker task with smoking 
and neutral pictures 
RTs: HC (and not ND) show 
posterror slowing 
ERN error: ND < HC at FCz, Cz, CPz  
ERN correct: no group differences  
Pe error: ND < HC at FCz, Cz, CPz  
Pe correct: no group differences 
de Ruiter et al.62 
(2012)*† 
18 ND 
17 HC 
fMRI 
Stop-signal task 
No group differences Contrast: stop E – control 
ND < HC: r-dACC 
ND > HC: r-DMPFC 
Nestor et al.63
(2011)* 
13 ND 
10 ex-ND 
13 HC 
fMRI  
Go/no-go task 
RTs:  
ND & HC < ex-ND 
ERRORs:  
ND > ex-ND & HC 
Contrast: no-go E v. baseline 
ND < HC: r-SFG, l-STG 
ND < ex-ND: r-SFG, l-ACC, l-PCC, l-MTG, l-cerebellum 
ND & HC < Ex-ND: bil-SFG, r-MFG, l-MTG, bil-PHG,  
l-cerebellum 
Ex-ND > HC : l-SFG, r-MFG, l-insula, bil-STG 
Alcohol dependence  
Padilla et al.102
(2011) 
14 AD 
14 HC 
ERPs 
Flanker task with high and 
low conflict and stimuli and 
response  
No group differences ERN error: AD > HC at FCz 
ERN correct: AD > HC at FCz 
Pe: not investigated 
Schellekens 
et al.103 (2010) 
29 AD 8 with and 21 
without ANX 
15 HC 
ERPs  
Flanker task 
RTs: AD > HC  
Errors: AD > HC 
ERN error: AD > HC at FCz; AD ANX+ > AD ANX- at FCz
ERN correct: not investigated 
Pe: not investigated 
Li et al.75 (2009)* 24 AD 
24 HC 
fMRI 
Stop-signal task 
No group differences Contrast: stop E – stop C 
AD > HC: bil-MTG, bil-SPL, bil-SFG, bil-MFG, r-CS, 
l-ACC, r-SOG, r-MOG  
Corr. posterror RTs 
AD < HC: r-DLPFC 
Cannabis dependence 
Hester et al.81
(2009)* 
16 CaD 
16 HC 
fMRI  
Go/no-go task with error 
awareness and 
unawareness 
Error awareness:  
CaD < HC 
Contrast: no-go E aware v. baseline 
CaD > HC: bil-precuneus, l-putamen, left caudate,  
l-hippocampus  
Contrast: no-go E unaware v. baseline 
CaD (and not HC) hypoactivation in  
r-ACC, r-putamen, r-IPL, bil -MFG  
Stimulant dependence 
Franken et al.7
(2007) 
14 CoD  
13 HC 
ERPs 
Flanker task 
Errors: CoD > HC 
Repeated errors: CoD > 
HC 
ERN error: CoD < HC at Fz, FCz, Cz 
ERN correct: no group differences 
Pe error: CoD < HC at Fz, FCz, Cz 
Pe correct: no group differences 
Marhe et al.105 
(2013) 
49 CoD 
23 HC 
ERPs 
Flanker task 
Errors: CoD > HC ERN error: CoD < HC at Fz, FCz, Cz 
ERN correct: no group differences 
Less pronounced ERN amplitudes in CoD at start of 
treatment were associated with more cocaine use at 3-mo 
follow-up. 
Pe: not investigated 
Sokhadze et al.85
(2008)* 
6 CoD  
6 HC 
ERPs 
Combined Flanker and 
go/no-go task 
RTs: CoD > HC 
Errors: CoD > HC 
ERN error: CoD < HC at frontal cluster 
ERN correct: no group differences 
Pe: not investigated 
Kaufman et al.87 
(2003)* 
13 CoD  
14 HC 
fMRI  
Go/no-go task 
Errors: CoD > HC Contrast: no-go E v. baseline 
CoD < HC: r-medFG, l-IFG, r-dACC, l-insula 
Luo et al.89 (2013) 97 CoD fMRI 
Stop-signal task 
n/m Cpots--Epots:tsartnoC
Relapsers < nonrelapsers: dACC in men and women, 
thalamus in women, l-Insula in men. 
Relapsers > nonrelapsers: none 
Opiate dependence
Forman et al.106 
(2004) 
13 OD 
13 HC 
fMRI  
Go/no-go task 
RTs: OD > HC 
Errors: OD > HC 
Contrast: no-go E v. baseline 
OD < HC: r-ACC 
Behavioural addictions 
Littel et al.96
(2012)* 
25 EG 
27 HC 
ERPs 
Go/no-go task 
Error: EG > HC 
Go RT:EG < HC 
ERN error: EG < HC at Fz, FCz, Cz, Pz 
ERN correct: no group differences 
Pe error: no group differences 
Pe correct: no group differences 
de Ruiter et al.62
(2012)*† 
18 PG 
17 HC 
fMRI 
Stop-signal task 
No group differences lortnoc--Epots:tsartnoC
PG < HC: r-dACC 
ACC = anterior cingulate cortex; AD = alcohol dependence; ANX+ = high levels of anxiety, ANX- = low levels of anxiety; bil- = bilateral; CaD = cannabis dependence, CoD = cocaine dependence; 
corr = correlation; CS = central sulcus; dACC = dorsal anterior cingulate cortex; DLPFC = dorsolateral prefrontal cortex; DMPFC = dorsomedial prefrontal cortex; EG = excessive gaming;  
ERN = error-related negativity; ERP = event-related potential; fMRI = functional magnetic resonance imaging; HC = healthy controls; IPL = inferior parietal lobe; l- = left; medFG = medial frontal 
gyrus; MFG = middle frontal gyrus; MOG = middle occipital gyrus; MTG = middle temporal gyrus; ND = nicotine dependence; no-go E = no-go error; OD = opiate dependence; Pe = error 
positivity; PCC = posterior cingulate gyrus; PG = pathological gambling; PHG = parahippocampal gyrus; r- = right; RT = reaction time; SOG = superior occipital gyrus; SPL = superior parietal lobe; 
STG = superior temporal gyrus; stop C = no-go correct; stop E = no-go error. 
*Study is also included in the inhibitory control section.  
†This study includes an ND, PG and HC group and therefore is included in both ND and behavioural addiction sections. 
Inhibitory control and error processing in  substance dependence and behavioural addictions
J Psychiatry Neurosci 2014;39(3) 159
levels for individuals with alcohol dependence and controls.74
The fMRI studies using the stop-signal task in participants
with alcohol dependence and controls did not show group
differences in SSRTs.75,76 Nevertheless, lower activation pat-
terns associated with inhibitory control in the left DLPFC in
those with alcohol dependence could be demonstrated.75 In a
pharmacological intervention study, effects of a single dose
of the cognitive enhancer drug modafinil on response inhib -
ition and underlying neural correlates were investigated in a
randomized, double-blind, placebo-controlled crossover
study.76 No main effect of modafinil on SSRT was observed.
However, a positive correlation between SSRT after placebo
and improvement in SSRT after modafinil suggests that par-
ticipants with lower baseline inhibitory control may benefit
from modafinil. The change in SSRT in individuals with alco-
hol dependence after modafinil administration was associ-
ated with increased activation in the left SMA and right ven-
trolateral thalamus, suggesting that this may be the neural
correlate of improved inhibitory control after modafinil ad-
ministration in patients with poor baseline inhibitory control.
Summary: As only 1 study evaluated N2 amplitudes, no firm
conclusions can be formulated regarding early inhibitory
control processes in individuals with alcohol dependence.
Evidence for neural deficits on P3 amplitudes reflecting
 inhibitory control in these individuals is weak, most likely
owing to large methodological differences among studies
and general study limitations. Some findings in the studies
we reviewed suggest that P3 deficits in individuals with alco-
hol dependence during inhibition-related task performance
may be due to general cognitive deficits, such as attention.
Specific behavioural deficits for inhibitory control were not
convincingly shown in either ERP or fMRI studies, which is
in line with conflicting findings in behavioural studies in this
domain.77–80 While the number of fMRI studies is limited,
available fMRI results suggest that activation in the DLPFC
related to inhibitory control in individuals with alcohol
 dependence may be dysfunctional. Furthermore, inhibitory
control in patients with poor baseline inhibitory control may
be improved with the cognitive enhancer modafinil.
Inhibitory control in individuals with cannabis dependence
Currently, no published ERP studies involving individuals
with cannabis dependence have evaluated N2 or P3 ampli-
tudes in the context of inhibitory control, whereas 2 fMRI
studies have been published.81,82 Neither fMRI study found in-
hibitory control deficits in individuals with cannabis depend -
ence  (using go/no-go tasks), which is line with the results of
nonimaging studies in similar populations.83,84 However, indi-
viduals actively using cannabis showed increased activation
during inhibitory control relative to controls in the  ACC/pre-
SMA, right IPL and putamen.81 These findings can be inter-
preted as a compensatory neural mechanism, given that indi-
viduals with cannabis dependence did not show behavioural
deficits. A similar result was also found in abstaining adoles-
cents with cannabis dependence, who showed increased acti-
vation during inhibitory control relative to controls in a large
network of brain regions (Table 2).82 However, activation in
part of these regions was also higher in those with cannabis
dependence than controls during go trials, suggesting that
not all differences between groups were specific for in-
hibitory control.
Summary: Clearly, more research is needed to confirm initial
fMRI findings that individuals with cannabis dependence
need greater neural activation in prefrontal and parietal re-
gions to perform inhibition tasks at the same level as controls.
In addition, the time course of possible neural deficits in indi-
viduals with cannabis dependence should be investigated by
measuring N2 and P3 amplitudes.
Inhibitory control in individuals with stimulant dependence
In 1 ERP study, N2 and P3 amplitudes were evaluated in a
Flanker task that incorporated no-go trials in currently using
individuals with cocaine dependence.85 The study found that
enhancement of no-go N2 and P3 amplitudes relative to go
amplitudes was less pronounced in individuals with cocaine
dependence than controls. However, behavioural findings
did not show differences in accuracy, such that ERP results
should be interpreted cautiously.
We included 6 fMRI studies in this section, 5 of which in-
volved patients with cocaine dependence and 1 involved pa-
tients with methamphetamine dependence. The studies of
Hester and Garavan86 and Kaufman and colleagues87 both
found lower no-go accuracy in individuals currently using
cocaine accompanied by reduced activation in the ACC/pre-
SMA compared with controls. Less brain activation associ-
ated with inhibitory control in those with cocaine depend -
ence relative to controls was found in the right superior
frontal gyrus86 and right insula.87 The go/no-go task in the
study by Hester and Garavan86 involved different levels of
working memory load in an attempt to mimic the high work-
ing memory demands resulting from drug-related rumina-
tions. The hypoactivation associated with inhibitory control
in the ACC was most pronounced when working memory
load was high, suggesting that inhibitory control is most
compromised in situations requiring high working memory
demands. Using a stop-signal task, Li and colleagues88 con-
firmed hypoactivation associated with inhibitory control in
the ACC in abstaining individuals with cocaine dependence
relative to controls; this hypoactivation was extended to the
bilateral superior parietal lobe (SPL) and left inferior occipital
gyrus. However, no differences were found between groups
regarding behavioural measures reflecting inhibitory control
(SSRTs), which is in contrast to findings from the studies
 using go/no-go tasks in active users. No association between
inhibitory  control–related brain activation and relapse rates
after 3 months was found in a study of abstaining individuals
with cocaine dependence.89
Two fMRI studies involving patients with stimulant depend -
ence investigated possible strategies to improve inhibitory
control. A pharmacological fMRI study in abstaining patients
with cocaine dependence90 showed that methyl phen idate ad-
ministration enhanced inhibitory control in these individuals
(i.e., the SSRT was shorter after methylphenidate administra-
tion). Furthermore, methylphenidate-induced decreases in
SSRT were positively correlated with activation in the left
MGF and negatively correlated with activation in the right
ventromedial prefrontal cortex, suggesting that these regions
may constitute a biomarker for the methylphenidate-induced
increase in inhibitory control. Generally, methylphenidate in-
creased brain activation during inhibitory control in the bilat-
eral striatum, bilateral thalamus and right cerebellum and de-
creased activation in the right superior temporal gyrus (STG).
These differences in activation may also indirectly contribute
to the improvement in inhibitory control due to methylpheni -
date. Another study in abstaining individuals with metham-
phetamine dependence that used a go/no-go task, did not
find evidence for impaired performance or brain activation
associated with inhibitory control in these individuals.91 Nev-
ertheless, the study found that accuracy for no-go trials was
enhanced in individuals with methamphetamine dependence
(and not in controls) when no-go trials were preceded by an
explicit warning cue that signalled the need for inhibition on
the next trial. In addition, individuals with methamphetamine
dependence showed increased activation in the ACC for
warning cues, which was positively correlated with improved
accuracy. These findings imply that inhibitory control can be
improved by explicit environmental cues that predict the
need for inhibitory control via preactivation of the ACC. Al-
ternatively, individuals with methamphetamine dependence
may benefit from exogenous cues by boosting attention to 
no-go stimuli. However, a first attempt to link inhibitory
 control–related brain activation with relapse did not identify
brain regions that differentiated between patients who re-
lapsed and those who remained abstinent.89
Summary: Several conclusions can be drawn from the neuro -
imaging studies in individuals with stimulant dependence.
First, the single ERP study in those with cocaine dependence
suggests that neural deficits may be present in both early and
late stages of the inhibition process; however, it is unclear
whether this may result in behavioural deficits. Second, hy-
poactivation in the ACC during inhibitory control in individ-
uals with cocaine dependence was found, which was associ-
ated with impaired task performance in 2 studies. Third,
explicit external cues and methylpheni date may both im-
prove inhibitory control by increasing activation associated
with inhibitory control in the medial prefrontal cortex.
Inhibitory control in individuals with opiate dependence
So far, 1 ERP study has investigated inhibitory control in ab-
staining individuals with opiate dependence in which no dif-
ferences between groups on no-go accuracy or N2 and P3
amplitudes were found.92 It should be noted, however, that
inhibitory requirements in this task were low given the high
probability of no-go trials (i.e., 50% of the trials were no-go
trials), so that the task may have been too easy to reveal dif-
ferences in inhibitory control between those with opiate de-
pendence and controls.
The single fMRI study included in this section used a
go/no-go task in which accuracy levels were deliberately
kept constant across individuals. Abstaining individuals with
opiate dependence were found to have slower go reaction
times and less brain activation than controls during task per-
formance in the key regions implicated in inhibitory control,
such as the bilateral ACC, medial PFC, bilateral IFG, left
MFG, left insula and right SPL.93 Hypoactivation in individ -
uals with opiate dependence was also extended to regions
outside the inhibitory control network into the left uncus, left
PHG, right precuneus and right MTG. However, go and no-
go stimuli in this study were presented in blocks, such that
inhibitory requirements were very low.
Summary: The single ERP study that we included did not
show deficits in inhibitory control and associated ERPs in ab-
staining patients with opiate dependence, whereas hypoactiva-
tion in medial, dorsolateral and parietal regions was found in
the fMRI study. Generally, studies investigating inhibitory con-
trol in individuals with opiate dependence are scarce and, as in-
hibitory requirements were low in both reviewed studies, fu-
ture studies could benefit from improvements in task design.
Inhibitory control in individuals with behavioural addictions
We included 3 ERP studies investigating inhibitory control in
people with behavioural addictions, 2 of which studied exces-
sive Internet use and 1 of which studied excessive gaming.
The ERP study by Zhou and colleagues94 showed less pro-
nounced no-go N2 amplitudes and lower no-go accuracy in
excessive compared with casual Internet users. The study did
not evaluate P3 amplitudes. Dong and colleagues95 confirmed
less pronounced no-go N2 amplitudes in men with excessive
Internet use than in those with casual Internet use, whereas P3
amplitudes in those with excessive Internet use were en-
hanced. No differences in behavioural performance were
found in the latter study. Enhanced activation in the final
stage of inhibitory control could have served as a compensa-
tion for the less efficient early inhibitory mechanisms in exces-
sive Internet users to obtain behavioural performance levels
equal to those of casual Internet users. Findings in a third ERP
study96 confirm problems with inhibitory control in individ -
uals with behavioural addictions, as excessive gaming in this
study was found to be associated with lower no-go accuracy.
The ERP findings, however, contradict those of the other
 studies by showing larger no-go N2 amplitudes in excessive
gamers in a parietal cluster compared with controls. Inconsis-
tencies in N2 findings may be the result of differences in
study population (a mixed group of excessive Internet users
versus a group with only excessive gaming behaviour) or dif-
ferences in task difficulty (> 91% no-go accuracy across
groups in the studies by Dong and colleagues95 and Zhou and
colleagues94 v. 53% in the study by Littel and colleagues96).
We included 4 fMRI studies in this section, 2 of which in-
volved individuals with pathological gambling and 2 of
which involved participants with excessive eating behaviours.
One of the fMRI studies of individuals with pathological gam-
bling reduced activation in the dACC for successful stops in a
stop-signal task relative to controls.62 Although  SSRTs were
not impaired in the pathological gambling group, this finding
suggests hypoactivation in the dACC similar to that found in
individuals with substance dependence. Another study of in-
dividuals with pathological gambling that used a go/no-go
Luijten et al.
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task with neutral, gambling, positive and negative pictures
showed similar no-go accuracy rates for the pathological gam-
bling and control groups.97 However, those with pathological
gambling may have used a compensation strategy to perform
the task as accurately as controls, as go reaction times were
longer and brain activation associated with neutral inhibitory
control in the bilateral DLPFC and right ACC was higher in
the pathological gambling group than the control group. A
gambling-related context appears to facilitate response inhib -
ition in individuals with pathological gambling relative to
controls, as indicated by higher no-go accuracy during expos -
ure to gambling cues and lower brain activity in the DLPFC
and ACC in those with pathological gambling than controls.
Two fMRI studies investigating inhibitory control have
been performed in people with excessive eating behaviour
(i.e., obese patients or binge eaters). The study involving
obese patients98 used the stop-signal task. While similar  SSRTs
were found, obese patients showed less brain activation than
controls in major parts of the inhibitory control network (i.e.,
right SFG, left IFG, bilateral MFG, insula, IPL, cuneus, right
occipital regions and left MTG). In the study by Lock and col-
leagues,99 similar accuracy levels were found during a go/no-
go task, while participants with binge eating behaviour had
more brain activation associated with inhibitory control than
controls in brain regions critically involved in inhibitory con-
trol, such as the right DLPFC, right ACC, bilateral precentral
gyri, bilateral hypothalamus and right MTG.
Summary: Event-related potential findings in excessive Inter-
net users showed reduced N2 amplitudes in 2 studies, sug-
gesting a deficit in the conflict detection stage of the inhib ition
process. In contrast, N2 amplitudes in people with excessive
gaming behaviour were enhanced in a parietal cluster. One
fMRI study in individuals with pathological gambling
showed hypoactivation associated with inhibitory control in
the dACC, while a second fMRI study showed that inhibitory
control and related brain activation may be boosted by a
 gambling-related context. Findings of the 2 fMRI studies in
people with excessive eating behaviour seem to partly contra-
dict each other. While neither study showed behavioural
deficits in inhibitory control, 1 study showed hyperactivation
in patients whereas the other showed hypoactivation in sub-
stantial parts of the inhibitory control network. Clearly, more
neuroimaging studies in populations with excessive addiction-
like behaviours are necessary.
Error processing
Error processing in individuals with nicotine dependence
Two ERP and 2 fMRI studies have examined error processing
in individuals with nicotine dependence. Franken and col-
leagues100 found that Flanker task performance and ERN am-
plitudes for incorrect trials were not impaired in individuals
with nicotine dependence after 1 hour of smoking abstinence.
However, Pe amplitudes were lower in these individuals
than in controls. These findings may indicate that initial error
detection in individuals with nicotine dependence is intact
but that more conscious evaluation of errors may be less dis-
tinct in this group. Luijten and colleagues101 used a similar
task in a study of individuals with nicotine dependence after
1 hour of abstinence, but also included smoking cues. Both
ERN and Pe amplitudes were lower in those with nicotine
dependence than controls. In addition, smokers displayed
less post-error slowing than controls. Results of this study
and that of Franken and colleagues100 suggest that initial error
detection may be specifically compromised in individuals
with nicotine dependence when limited cognitive resources
are available for error monitoring (e.g., during exposure to
smoking cues). On the other hand, the more conscious pro-
cessing of errors may be generally less distinct in individuals
with nicotine dependence.
An fMRI study in which participants performed a stop-
 signal task showed less error-related activation in individuals
with nicotine dependence than controls in the dACC coupled
with increased activation in an anterior region of the dorso-
medial prefrontal cortex (DMPFC).62 Using a go/no-go task,
Nestor and colleagues63 found that nonabstaining individuals
with nicotine dependence, as compared with controls, made
more errors accompanied by reduced brain activation after
performance errors in the right SFG and left STG, whereas no
difference was found in either the ACC or insula. This study
also included a group of ex-smokers who were abstinent for
at least 1 year and showed enhanced error-related activity in
the ACC, left insula, bilateral SFG, right MFG, left cerebel-
lum, left MTG, bilateral STG and bilateral parahippocampal
gyrus (PHG) relative to individuals with nicotine depend -
ence and controls. These findings suggest that more elaborate
neural monitoring of errors may increase the probability to
quit smoking or that the deficits in individuals with nicotine
dependence are reversible.
Summary: Results from the 2 ERP studies suggest that initial er-
ror detection may be less effective in individuals with nicotine
dependence during more cognitively challenging situations,
whereas the more conscious evaluation of errors may also be
compromised in affectively neutral conditions. Hypo activation
in the ACC in reaction to errors was found in 1 of the 2 fMRI
studies in individuals with nicotine dependence. Further re-
search should clarify under which conditions neural deficits as-
sociated with error processing are present in these individuals.
Error processing in individuals with alcohol dependence
Two ERP studies and 1 fMRI study have investigated error
processing in abstinent patients with alcohol dependence.
Padilla and colleagues102 and Schellekens and colleagues103 in-
vestigated ERN (but not Pe) amplitudes in abstaining indi-
viduals with alcohol dependence evoked by errors on a
Flanker task. The alcohol dependence group in the study by
Padilla and colleagues102 performed the task as accurately as
the control group but showed increased ERN amplitudes,
suggesting enhanced monitoring of performance errors.
However, this may not be specific for errors in this study,
since the alcohol dependence group also showed increased
amplitudes for correct trials. Another ERP study in indi -
viduals with alcohol dependence found increased ERN
 amplitudes specifically for errors in patients with alcohol
 dependence relative to controls.103 In addition, these alcohol-
 dependent patients showed increased error rates for con -
gruent trials. Interestingly, when individuals with alcohol
 dependence and comorbid anxiety disorders were compared
with those without anxiety disorders, ERN amplitudes were
larger in the anxiety subgroup. Enhanced ERN amplitudes in
highly anxious individuals is in line with theories suggesting
that internalizing psychopathology is associated with in-
creased monitoring of performance errors.104 In line with ERP
findings, an fMRI study by Li and colleagues75 showed in-
creased error-related brain activation in individuals with al-
cohol dependence relative to controls in a stop-signal task in
the right ACC, bilateral MFG and bilateral SFG as well as in
regions outside the error processing network (i.e., the bilat-
eral MTG, SPL, right central culcus and right superior and
middle occipital gyrus).
Summary: It appears that the processing of errors is en-
hanced in abstaining individuals with alcohol dependence, as
ERN amplitudes and error-related ACC activation were in-
creased. Currently, none of the ERP studies in individuals
with alcohol dependence evaluated Pe amplitudes; therefore,
no information is available regarding more conscious pro-
cessing of errors in this group.
Error processing in individuals with cannabis dependence
No ERP studies and only 1 fMRI study investigating error
processing in individuals with cannabis dependence were
identified.81 In the fMRI study, participants were asked to
press a button in a go/no-go task when they noticed that
they made a mistake, such that aware and unaware errors
could be evaluated separately. For aware errors, activation in
regions critical for error processing was similar in  non–
treatment seeking individuals with cannabis dependence and
controls, whereas cannabis-dependent individuals showed
more error-related brain activation in the bilateral precuneus
and left putamen, caudate and hippocampus. The proportion
of errors in cannabis-dependent individuals and controls was
similar; however, the cannabis-dependent individuals were
less often aware of their errors. In addition, cannabis-
 dependent individuals, but not controls, showed less activa-
tion in the right ACC, bilateral MFG, right putamen and IPL
for unaware errors than aware errors. The difference in error-
related ACC activity for aware and unaware errors was posi-
tively associated with reduced error awareness.
Summary: More fMRI studies are needed to confirm less pro-
nounced error awareness in cannabis users. Also, ERP studies
should evaluate whether the initial automatic stage of error
processing may also be compromised and should replicate
less distinct error awareness in individuals with cannabis
 dependence by evaluating Pe amplitudes.
Error processing in individuals with stimulant dependence
Three ERP studies investigated error processing in individuals
with cocaine dependence.7,85,105 No studies in populations using
other stimulants were identified. Participants in the study by
Franken and colleagues7 performed a Flanker task. Event-
 related potential findings showed that both the initial auto-
matic processing of errors and the later more conscious pro-
cessing of errors is less pronounced in abstaining individuals
with cocaine dependence than controls, as both ERN and Pe
amplitudes were attenuated. Furthermore, participants with
cocaine dependence committed more errors than controls.
More specifically, they committed more errors after an error
on the previous trial, which suggests that behavioural adapta-
tion was suboptimal. Sokhadze and colleagues85 and Marhe
and colleagues105 confirmed increased error rates and reduced
ERN amplitudes in individuals with cocaine dependence rela-
tive to controls performing, respectively, a combined Flanker
and go/no-go task in active users and a classic Flanker task in
cocaine-dependent patients in the first few days of detoxifica-
tion. Neither study investigated Pe amplitudes. Importantly,
reduced ERN amplitudes were also shown to be predictive for
increased cocaine use at 3-month follow-up.105
Two fMRI studies in individuals with cocaine dependence
investigated brain activation associated with error processing
employing a go/no-go87 and a stop-signal task.89 Error-related
hypoactivation was found in those who were actively using
cocaine compared with controls in the ACC, right MFG, left
insula and left IFG. In addition, individuals with cocaine
 dependence committed more errors during task performance.
In line with ERP findings, Luo and colleagues89 showed that
reduced error-related dACC activation in abstaining individ-
uals with cocaine dependence was associated with relapse
rates 3 months later in both men and women, while sex-
 specific effects were found in the thalamus and the left insula.
Summary: Both ERP and fMRI studies show less error-
 related brain activation in individuals with cocaine depend -
ence than controls, especially in regions critical for optimal
error processing, such as the ACC, insula and IFG. Lower
ERN and Pe amplitudes in individuals with cocaine depend -
ence compared to controls suggest that problems with error
processing may emerge as both a consequence of deficits in
initial error detection as well as from deficits in the more con-
scious evaluation of performance errors. Reduced ERN am-
plitudes and error-related dACC activation were associated
with relapse at 3-month follow-up.
Error processing in individuals with opiate dependence
We identified no ERP studies and only 1 fMRI study that in-
vestigated error processing in abstaining individuals with
opiate dependence.106 It was found that individuals with
opiate dependence made more errors in a go/no-go task
and that error-related activation in the ACC was reduced
compared with activation in controls. Furthermore, an asso-
ciation between ACC activation and behavioural perform -
ance in individuals with opiate dependence was lacking,
whereas this brain–behaviour correlation was present in
controls.
Summary: Neural deficits in error-related brain activation in
the ACC in individuals with opiate dependence were found
in an fMRI study. Obviously, more fMRI and ERP studies are
needed to confirm differences in these patients.
Luijten et al.
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Error processing in individuals with behavioural addictions
We identified only 1 ERP study in the domain of behavioural
addictions that showed increased errors rates for no-go trials in
people with excessive gaming behaviour compared with con-
trols.96 Lower ERN amplitudes and no differences in Pe ampli-
tudes were found in participants with excessive gaming for er-
ror trials, suggesting that initial error processing in excessive
gamers may be less pronounced than in controls, whereas error
awareness may not be related to increased  error rates. The only
fMRI study that investigated error  processing in the context of
behavioural addictions showed that error-related brain activa-
tion in the dACC on the stop-signal task was lower in individ -
uals with pathological gambling behaviour than controls,
whereas task performance was intact.62 This finding suggests a
less pronounced monitoring of errors in the pathological gam-
bling group in the most important region for error processing.
Summary: Both studies investigating error processing
showed less processing of errors in individuals with excessive
 addiction-like behaviours, thereby resembling findings in in-
dividuals with substance dependence. Additional fMRI and
ERP  studies are needed to replicate these findings and extend
them to other groups showing behavioural addictions.
Discussion
Summary of results
The present review provides an overview of ERP and fMRI
studies that have addressed inhibitory control and error pro-
cessing in individuals with substance dependence and in indi-
viduals showing proposed behavioural addictions. The ERP
studies of inhibitory control, as operationalized using go/no-
go and stop-signal paradigms, have found deficits in N2 and
P3 amplitudes in individuals with addictions. Of the studies
that evaluated N2 amplitudes (n = 7), most (n = 5) showed
lower N2 amplitudes in individuals with addictions than con-
trols (for an example, see the Appendix, Fig. S1, at jpn .ca),
suggesting that deficits in inhibitory control in individuals
with addictions could be caused by problems with early cog-
nitive processes, such as conflict detection. Results of studies
on P3 amplitudes (n = 11) are inconsistent. Some studies
showed no differences between individuals with addictions
and controls (n = 5), whereas other studies showed lower (n =
5) or higher (n = 1) P3 amplitudes in those with addictions.
Therefore no clear conclusions can be formulated with regard
to the P3. Complementary to findings of less pronounced N2
Fig. 1: Summary of anterior cingulate dysfunction in individuals with
addictions for inhibitory control. Circles represent hypoactivation
and squares hyperactivation for inhibitory control in individuals with
addictions relative to controls. Of note, 6 studies included in this re-
view reporting group differences are not displayed in this figure, as
results did not indicate group differences in the anterior cingulate
cortex for inhibitory control–related brain activation. Red: opioid
 dependence; green: cocaine dependence; dark blue: cannabis
 dependence; light blue: nicotine dependence; yellow: behavioural
addictions. Locations are based on reported Talairach or Montreal
Neurological Institute (MNI) coordinates in studies reporting group
differences included in this review. Talairach coordinates were con-
verted to MNI using the GingerALE toolbox. Foci of activation were
projected onto the midline for ease of viewing.
Fig. 2: Summary of anterior cingulate dysfunction in individuals with
addictions for error processing. Circles represent hypoactivation
and squares hyperactivation for error processing in individuals with
addictions relative to controls. Of note, 1 study included in this re-
view that reports group differences is not displayed in this figure as
results did not indicate group differences in the anterior cingulate
cortex for error-related brain activation. Red: opioid dependence;
green: cocaine dependence; purple: alcohol dependence; light
blue: nicotine dependence; yellow: pathological gambling. Loca-
tions are based on reported Talairach or Montreal Neurological In-
stitute (MNI) coordinates in studies reporting group differences in-
cluded in this review. Talairach coordinates were converted to MNI
using the GingerALE toolbox. Foci of activation were projected onto
the midline for ease of viewing.
amplitudes, several fMRI studies (n = 13 of 16) found hy-
poactivation associated with inhibitory control in individuals
with addictions, mainly in the ACC, IFG and DLPFC, but
also in the inferior and superior parietal gyri (Fig. 1). From
these findings, it can be concluded that substantial parts of
the network underlying inhibitory control are dysfunctional
in individuals with addictions. Of note, differences in brain
activation associated with inhibitory control were also found
outside the inhibitory control neural network, signifying that
individuals with addictions may use different strategies to
implement inhibitory control.
Error-related hypoactivation in individuals with addictions
in the ACC, the most critical area for error processing, was
found in most (n = 6 of 7) fMRI studies (Fig. 2), while hypo -
activation associated with error processing was also reported
in other regions, such as the superior and inferior frontal gyri
and insula. The ERP findings confirm and complement fMRI
findings. Lower ERN amplitudes in individuals with addic-
tions relative to controls were observed (n = 5 of 8), thereby
confirming initial error-detection deficits in individuals with
addictions (see the Appendix, Fig. S2, for an example of ERN
and Pe findings). Given that the ACC is the neural generator
of the ERN,8,48,49 both ERN and fMRI findings suggest that
ACC dysfunction could be a biomarker for error processing
deficits in individuals with addictions. Importantly, lower
ERN amplitudes and hypoactivation in the ACC was associ-
ated with relapse in 2 longitudinal  studies.89,105 Pe findings
complement fMRI findings by providing information on the
time frame of error processing deficits. Lower Pe amplitudes
in individuals with substance dependence compared with
controls were observed (n = 3 of 4) and suggest that, besides
the initial error detection, more conscious processing of er-
rors may also be compromised. This is a particularly interest-
ing finding as it may be associated with impaired insight in
behaviour, a topic that recently attracted more attention in
the field of addiction.107
Two findings in the present review constitute an exception
to the conclusions discussed. First, fMRI findings in cannabis
users show hyper- instead of hypoactivation with regard to
inhibitory control in brain regions critically involved in in-
hibitory control, including the pre-SMA, DLPFC, insula and
IPG. Hyperactivation associated with inhibitory control in
cannabis users can be interpreted as increased neural effort to
reach control sample levels of behaviour performance (i.e., no
behavioural deficits were found in these individuals). An-
other explanation for hyperactivation in this population is the
comparatively young age of cannabis users in both fMRI
studies relative to other studies in individuals with substance
dependence.81,82 In addition, participants in the study by
 Tapert and colleagues82 abstained from cannabis use for
28 days, which is longer than in most other studies, suggest-
ing that brain activation may change as a function of abstin -
ence duration.108
The ERP and fMRI findings regarding error processing in
individuals with alcohol dependence constitute the second
exception on the generally observed error-related hypoacti-
vation in individuals with addictions. In contrast to other
populations with addictions, those with alcohol dependence
show enhanced error processing, as reflected by enlarged
ERN amplitudes and increased error-related activation in the
ACC.75,102,103 Findings in the study by Schellekens and col-
leagues103 provide a possible explanation for enhanced error
processing in alcohol-dependent individuals, as ERN ampli-
tudes were larger in highly anxious individuals than in less
anxious individuals. This suggests that the often observed co-
morbid internalizing psychopathology (i.e., anxiety-related
disorders) in individuals with alcohol dependence109,110 may
be responsible for the enhanced error processing. An
overview of ERN findings confirms that internalizing psycho -
pathology is associated with larger ERN amplitudes, whereas
externalizing psychopathology is associated with less pro-
nounced ERN amplitudes.104
A secondary goal of our review was to evaluate differences
and similarities in inhibitory control and error processing be-
tween substance dependence and other addictive behaviours.
Similar findings to those observed in individuals with sub-
stance dependence were found in people with pathological
gambling and excessive eating, gaming and Internet use. For
example, hypoactivation in the ACC for both inhibitory con-
trol and error processing was found in individuals with
pathological gambling behaviour,62 which resembles the most
often observed finding in individuals with substance depend -
ence. However, contradictory findings have also been identi-
fied in those with excessive gaming behaviour (e.g., enlarged
N2 amplitudes) and excessive eating behaviour (i.e., 1 fMRI
study in the domain of inhibitory control showed hypoacti-
vation during an inhibition task, whereas the other showed
hyperactivation). In conclusion, some similarities between in-
dividuals with substance dependence and those showing ad-
dictive behaviours were identified; however, there remains
insufficient neuroimaging research in these populations, and
current findings are inconclusive.
Integrative model
The integration of ERP and fMRI findings for both inhibitory
control and error processing results in the observation that
most consistent findings in individuals with addictions are all
related to dysfunction of the dACC. Both the N2 and the ERN
have their neural origin in the dACC,111 and dACC dysfunction
was the most consistent fMRI finding for both inhibitory con-
trol and error processing. This suggests that a shared dysfunc-
tion of the dACC may contribute to deficits in both inhibitory
control and error processing. An influential theory concerning
the function of the dACC suggests that conflict monitoring is
the core function of the dACC,8,112 thereby explaining its crucial
role in many different cognitive functions. This theory is sup-
ported by the finding that  conflict-related activation in the
dACC precedes increased activation in the DLPFC on the next
trial, showing that the dACC precedes adjustment in activa-
tion in other brain regions that implement cognitive control.59
This conflict monitoring function of the dACC may be a critical
function for both inhibitory control and error processing. For
inhibitory control, a conflict between the automatic response
tendency and the long-term goal needs to be detected to in-
hibit behaviour. Error processing and conflict monitoring may
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even be more tightly related, probably in a reciprocal way. To
be able to process errors during ongoing behaviour, the moni-
toring of conflict is crucial to signal the difference between the
actual response and the representation of the correct response.
On the other hand, an optimal processing of performance er-
rors is necessary for learning and conflict monitoring in future
behaviour, thereby illustrating a possible reciprocal relation-
ship between conflict monitoring and error processing. This
reciprocal association with conflict monitoring (Fig. 3) suggests
that error processing deficits may indirectly influence other
functional domains of cognitive control, including inhibitory
control.113 Altogether, we propose that disturbed conflict moni-
toring in the dACC represents a core deficit in individuals
with addictions under lying the observed deficits in error pro-
cessing and inhibitory control (Fig. 3). Notably, this idea of
conflict monitoring as a common deficit in dACC functioning
in individuals with addictions may generalize to other do-
mains of cognitive control, including feedback processing, at-
tentional monitoring and salience detection. In line with this
idea, some of these functions, such as salience detection meas -
ured in oddball paradigms, have previously been shown to be
impaired in individuals with addictions,114 whereas other func-
tions, such as attentional monitoring, constitute a crucial part
of many cognitive control functions, including inhibitory con-
trol. Given the proposed role of the IFC in go/no-go and stop-
signal task paradigms, the observed IFG deficits in individuals
with addictions during these tasks may reflect reduced atten-
tional monitoring capacities.19,20,115 Based on the postulated
model it can be expected that improvement of dACC function-
ing,  either through direct neuromodulation or indirect behav-
ioural therapies would result in increased control over addic-
tive behaviours. Another hypothesis based on the current
model would be that interventions targeting conflict monitor-
ing or error processing would concomitantly result in im-
provements in inhibitory control, while this would not neces-
sarily work in the opposite direction.
Limitations
It is crucial to note that inconsistencies in findings within and
among included studies were evident. For example, brain
and behavioural findings were not always consistent and in-
dividuals with addictions showed hyper- instead of hypo -
activation associated with inhibitory control or error process-
ing in some studies. Generally, the interpretation of hypo-
versus hyperactivation in ERP and fMRI studies in clinical
populations relative to controls remains equivocal. Behav-
ioural findings, such as less accurate task performance or
 reaction time differences, are key to guide the interpretation
of hypo- or hyperactivation. Although speculative, a possible
explanation for hypoactivation without behavioural deficits
is that brain activation may be a more sensitive measure to
detect abnormalities in individuals with addictions.5,116 In this
context it would be interesting to investigate associations be-
tween the amount of substance use or the level of depend -
ency and the extent of hypoactivation. On the other hand,
hyper activation coupled with intact behavioural performance
is often interpreted as increased neural effort or the use of al-
ternative cognitive strategies to achieve normal levels of be-
havioural performance.117
Inconsistencies in results are probably owing to differences
in methodology, such as patient selection, specifications of task
paradigms, data acquisition and analysis techniques. Although
we report several patient characteristics in Table 1, it is a limita-
tion of the present review that the effects of these characteristics
on neuroimaging results could not be evaluated owing to the
large variability and the limited number of studies. In particu-
lar, abstinence duration has been shown to alter cognitive con-
trol and associated brain function.118 Therefore, longitudinal
studies are clearly needed to unravel the developmental trajec-
tory of cognitive deficits after prolonged periods of drug abstin -
ence. A further limitation is that it was unclear in some studies
whether the researchers adequately controlled for nicotine use.
As the current review clearly showed differences in inhibitory
control and error processing and related brain activation in
smokers versus nonsmokers, nicotine use should be taken into
account in studies of other populations with addictions. 
Error processing 
Conflicting situation in terms of 
short versus long-term goals 
dACC conflict monitoring 
Inhibitory control 
 ERN dACC 
N2 
dACC 
DLPFC 
IFG  
PG 
Loss of control over addiction-related 
behaviours 
Fig. 3: Summary and integrative model of neural deficits in error
processing and inhibitory control in individuals with addictive behav-
iours. The event-related potential components and brain regions
listed in the boxes are those showing the most consistent neural
deficits in individuals with addictions in error processing and in-
hibitory control. As the most consistent findings are related to dor-
sal anterior cingulate cortex (dACC) dysfunction, we suggest that
problems with conflict monitoring, a critical function of the dACC, in-
volved in both inhibitory control and error processing, may trigger
the loss of control in individuals with addictions. The grey arrow in-
dicates that the function of this highly interrelated system is de-
creased in individuals with addictions compared with healthy con-
trols. It further illustrates the negative impact of this dysfunctional
system over addiction-related behaviours. The arrows in the model
symbolize the relationships between error-processing and inhibitory
control with conflict monitoring. The dotted arrow represents the
modulatory effect of error-related dACC activation on connected
brain regions. DLPFC = dorsolateral prefrontal cortex; ERN = error-
related negativity; IFG = inferior frontal gyrus; PG = parietal gyrus. 
Another limitation of the present review is the small num-
ber of studies included for some substances of abuse, which
hampered firm conclusions in those groups. More studies are
needed, particularly in individuals with opiate and cannabis
dependence and in individuals showing excessive addiction-
like behaviours. In addition, we recommend that both ERN
and Pe, or N2 and P3 amplitudes be evaluated in a single
study to provide optimal information regarding the time
frame of cognitive control deficits.
With regard to task paradigms, it is a strength of the pre-
sent review that we selected only those task paradigms that
most closely reflect inhibitory control and error processing
(i.e., go/no-go, stop-signal and Flanker task), thereby redu -
cing variability in results owing to the different cognitive
pro cesses needed for task performance. On the other hand,
the narrow focus may be considered a limitation, as results
cannot be generalized to other cognitive domains or task par-
adigms. Studies using the Stroop task, for example, were ex-
cluded because the Stroop task is known to evoke cognitive
processes, such as conflict resolution, response selection and
attention23,24 as well as different ERP components compared
with go/no-go and stop-signal paradigms.119–121 Nevertheless,
some findings in fMRI and positron emission tomography
studies using the classic colour–word Stroop task are in line
with the present findings.122–124 Even with the strict selection of
task paradigms, there is still variance in outcomes within
go/no-go and stop-signal paradigms, which contributes to
inconsistencies in results across studies. Differences in analy-
sis techniques may further induce inconsistencies in results.
For fMRI studies, whole brain versus regions of interest
analyses and different methods to correct for multiple com-
parisons are major sources of variance, and so is the use of
different within-subject contrasts for subsequent between-
subject analyses (e.g., stop correct minus go v. stop correct
minus stop error). Task design and analysis techniques
should become much more standardized to reduce inconsis-
tencies in results. This is also a prerequisite if these para-
digms will eventually be implemented in clinical practice.
Treatment implications and future research directions
Contemporary effective treatments for addiction involve
pharmacotherapy, cognitive behaviour therapy and contin-
gency management.125–127 Nevertheless, relapse rates are still
high, so there is ample room for improvement. Several treat-
ment targets based on the findings in this review merit fur-
ther investigations. First, it has been shown that inhibitory
control capacities and underlying neural networks could be
trained to increase behavioural control.128 A second possibil-
ity to increase inhibitory control is the direct training of
hypo active brain regions, such as the ACC, IFG and DLPFC,
 using neuromodulation techniques.129–131 Specific medications
with the aim to enhance cognitive functions may be another
treatment intervention to increase cognitive functioning.132
More research into these clinical applications is needed to ex-
plore which of these potential treatment strategies may even-
tually be effective in the reduction of addictive behaviours.
Cognitive control capacities can also be used in clinical
practice to guide treatment strategies according to individual
needs. It has been shown that deficits in cognitive control are
associated with a reduced capacity to recognize problems
with substance abuse, lower motivation to enter treatment
and treatment dropout.133,134 Berkman and colleagues66 showed
that individual differences in activation in the inhibitory con-
trol network are linked to the ability to inhibit craving in daily
life to prevent smoking. These and other recent findings135
highlight the need to monitor cognitive control capacities dur-
ing treatment and may be used to identify individuals with
addictions who are more vulnerable to relapse.
One of the most important remaining questions is that of
causality. It is not yet known whether neural deficits associated
with inhibitory control and error processing in individuals with
addictions predispose them to substance use or whether they
are a consequence of substance use. Interestingly, a recent
study provided evidence for the ERN as a possible endopheno-
type for addiction,136 as ERN amplitudes were lower in high-
risk offspring than adolescents with a normal risk.
Conclusion
This review systematically evaluated ERP and fMRI findings
concerning inhibitory control and error processing in indi-
viduals with substance dependence and individuals showing
excessive addiction-like behaviours. The combined evalua-
tion of ERP and fMRI offers new insights and future research
directions. Overall, results show that addiction is associated
with neural deficits related to inhibitory control and error
processing. The most consistent findings were lower N2,
ERN and Pe amplitudes and hypoactivation in the dACC,
IFG and DLPFC in individuals with addictions compared
with controls. We propose an integrative model suggesting
that dACC dysfunction in conflict monitoring may be a core
neural deficit underlying addictive behaviours.  Finally, simi-
larities between individuals with substance dependence and
individuals showing addiction-like behaviours were identi-
fied, but evidence for neural deficits in the domains of in-
hibitory control and error processing in the latter population
is scarce and inconclusive.
Acknowledgements: This study was supported by a grant of the
Netherlands Organization for Scientific Research (NWO; VIDI grant
number 016.08.322). The funding organization had no role in prepa-
ration of the manuscript or decision for publication. The authors
have no competing interests to declare.
Competing interests: None declared.
Contributors: All authors designed the study, acquired and analyzed
the data and approved the final version to be published. M. Luijten
and M.W.J. Machielsen wrote the article, which D.J. Veltman, R. Hester,
L. de Haan and I.H.A. Franken reviewed.
References
1. Lubman DI, Yucel M, Pantelis C. Addiction, a condition of com-
pulsive behaviour? Neuroimaging and neuropsychological evi-
dence of inhibitory dysregulation. Addiction 2004;99:1491-502.
2. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dys-
Luijten et al.
166 J Psychiatry Neurosci 2014;39(3)
Inhibitory control and error processing in  substance dependence and behavioural addictions
J Psychiatry Neurosci 2014;39(3) 167
function in drug abuse: implications for the control of behavior by
reward-related stimuli. Psychopharmacology (Berl) 1999;146:
373-90.
3. Dawe S, Gullo MJ, Loxton NJ. Reward drive and rash impulsive-
ness as dimensions of impulsivity: implications for substance mis-
use. Addict Behav 2004;29:1389-405.
4. Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulner -
ability marker for substance-use disorders: review of findings
from high-risk research, problem gamblers and genetic association
studies. Neurosci Biobehav Rev 2008;32:777-810.
5. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in
addiction: neuroimaging findings and clinical implications. Nat
Rev Neurosci 2011;12:652-69.
6. Oscar-Berman M, Marinkovic K. Alcohol: effects on neurobehav-
ioral functions and the brain. Neuropsychol Rev 2007;17:239-57.
7. Franken IH, Van Strien JW, Franzek EJ, et al. Error-processing deficits
in patients with cocaine dependence. Biol Psychol 2007;75:45-51.
8. Ridderinkhof KR, Ullsperger M, Crone EA, et al. The role of the
medial frontal cortex in cognitive control. Science 2004;306:443-7.
9. Grant JE, Potenza MN, Weinstein A, et al. Introduction to behav-
ioral addictions. Am J Drug Alcohol Abuse 2010;36:233-41.
10. van Holst RJ, Van den Brink W, Veltman DJ, et al. Why gamblers
fail to win: a review of cognitive and neuroimaging findings in
pathological gambling. Neurosci Biobehav Rev 2010;34:87-107.
11. Potenza MN. Should addictive disorders include non-substance-
related conditions? Addiction 2006;101(Suppl 1):142-51.
12. Goudriaan AE, Oosterlaan J, De Beurs E, et al. The role of self-
 reported impulsivity and reward sensitivity versus neurocognitive
measures of disinhibition and decision-making in the prediction of
relapse in pathological gamblers. Psychol Med 2008;38:41-50.
13. Tomasi D, Volkow ND. Striatocortical pathway dysfunction in ad-
diction and obesity: differences and similarities. Crit Rev Biochem
Mol Biol 2013;48:1-19.
14. Dalley JW, Everitt B, Robbins T. Impulsivity, compulsivity, and
top-down cognitive control. Neuron 2011;69:680-94.
15. Chambers CD, Garavan H, Bellgrove MA. Insights into the neural
basis of response inhibition from cognitive and clinical neuro-
science. Neurosci Biobehav Rev 2009;33:631-46.
16. Verbruggen F, Logan GD. Response inhibition in the stop-signal
paradigm. [Regul Ed]. Trends Cogn Sci 2008;12:418-24.
17. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple
and choice reaction time responses: a model and a method. J Exp
Psychol Hum Percept Perform 1984;10:276-91.
18. Corbetta M, Shulman GL. Control of goal-directed and stimulus-
driven attention in the brain. Nat Rev Neurosci 2002;3:201-15.
19. Li CS, Huang C, Constable RT, et al. Imaging response inhibition
in a stop-signal task: neural correlates independent of signal moni-
toring and post-response processing. J Neurosci 2006;26:186-92.
20. Hampshire A, Chamberlain SR, Monti MM, et al. The role of the
right inferior frontal gyrus: inhibition and attentional control. 
Neuroimage 2010;50:1313-9.
21. Stroop JR. Studies of interference in serial verbal reactions. J Exp
Psychol Gen 1992;121:15-23.
22. Eriksen BA, Eriksen CW. Effects of noise letters upon the identifi-
cation of a target letter in a nonsearch task. Percept Psychophys
1974;16:143-9.
23. Nigg JT. On inhibition/disinhibition in developmental psy-
chopathology: views from cognitive and personality psychology
and a working inhibition taxonomy. Psychol Bull 2000;126:220-46.
24. Ridderinkhof KR, Van den Wildenberg WP, Segalowitz SJ, et al.
Neurocognitive mechanisms of cognitive control: the role of pre-
frontal cortex in action selection, response inhibition, performance
monitoring, and reward-based learning. Brain Cogn 2004;56:129-40.
25. Kok A, Ramautar JR, De Ruiter MB, et al. ERP components associ-
ated with successful and unsuccessful stopping in a stop-signal
task. Psychophysiology 2004;41:9-20.
26. Huster RJ, Westerhausen R, Pantev C, et al. The role of the cingu-
late cortex as neural generator of the N200 and P300 in a tactile re-
sponse inhibition task. Hum Brain Mapp 2010;31:1260-71.
27. Nieuwenhuis S, Yeung N, Van den Wildenberg W, et al. Electro-
physiological correlates of anterior cingulate function in a go/no-
go task: effects of response conflict and trial type frequency. Cogn
Affect Behav Neurosci 2003;3:17-26.
28. Lavric A, Pizzagalli DA, Forstmeier S. When ‘go’ and ‘nogo’ are
equally frequent: ERP components and cortical tomography. Eur J
Neurosci 2004;20:2483-8.
29. Falkenstein M. Inhibition, conflict and the Nogo-N2. Clin 
Neurophysiol 2006;117:1638-40.
30. Kaiser S, Weiss O, Hill H, et al. N2 event-related potential correl -
ates of response inhibition in an auditory go/nogo task. Int J 
Psychophysiol 2006;61:279-82.
31. van Boxtel GJ, Van der Molen MW, Jennings JR, et al. A psycho -
physiological analysis of inhibitory motor control in the stop-
 signal paradigm. Biol Psychol 2001;58:229-62.
32. Falkenstein M, Hoormann J, Hohnsbein J. ERP components in
go/nogo tasks and their relation to inhibition. Acta Psychol (Amst)
1999;101:267-91.
33. Dimoska A, Johnstone SJ, Barry RJ. The auditory-evoked N2 and
P3 components in the stop-signal task: indices of inhibition,
 response-conflict or error-detection? Brain Cogn 2006;62:98-112.
34. Ramautar JR, Kok A, Ridderinkhof KR. Effects of stop-signal
modality on the N2/P3 complex elicited in the stop-signal para-
digm. Biol Psychol 2006;72:96-109.
35. Band GPH, Van Boxtel GJM. Inhibitory motor control in stop para-
digms: review and reinterpretation of neural mechanisms. Acta
Psychol (Amst) 1999;101:179-211.
36. Garavan H, Hester R, Murphy K, et al. Individual differences in
the functional neuroanatomy of inhibitory control. Brain Res
2006;1105:130-42.
37. Simmonds DJ, Pekar JJ, Mostofsky SH. Meta-analysis of go/no-go
tasks demonstrating that fMRI activation associated with response
inhibition is task-dependent. Neuropsychologia 2008;46:224-32.
38. Mostofsky SH, Simmonds DJ. Response inhibition and response se-
lection: two sides of the same coin. J Cogn Neurosci 2008;20:751-61.
39. Li CS, Yan P, Sinha R, et al. Subcortical processes of motor response
inhibition during a stop signal task. Neuroimage 2008;41:1352-63.
40. Overbeek TJM, Nieuwenhuis S, Ridderinkhof KR. Dissociable
components of error processing: on the functional significance of
the Pe vis-à-vis the ERN/Ne. J Psychophysiol 2005;19:319-29.
41. Shiels K, Hawk LW Jr. Self-regulation in ADHD: The role of error
processing. Clin Psychol Rev 2010;30:951-61.
42. Rabbitt PM. Error correction time without external error signals.
Nature 1966;212:438.
43. Danielmeier C, Ullsperger M. Post-error adjustments. Front Psychol
2011;2:233.
44. Hewig J, Coles MGH, Trippe RH, et al. Dissociation of Pe and
ERN/Ne in the conscious recognition of an error. Psychophysiology
2011;48:1390-6.
45. Nieuwenhuis S, Ridderinkhof KR, Blom J, et al. Error-related brain
potentials are differentially related to awareness of response errors:
evidence from an antisaccade task. Psychophysiology 2001;38:752-60.
46. Bernstein PS, Scheffers MK, Coles MG. “Where did I go wrong?”
A psychophysiological analysis of error detection. J Exp Psychol
Hum Percept Perform 1995;21:1312-22.
47. Gehring WJ, Knight RT. Prefrontal-cingulate interactions in action
monitoring. Nat Neurosci 2000;3:516-20.
48. Herrmann MJ, Rommler J, Ehlis AC, et al. Source localization
(LORETA) of the error-related-negativity (ERN/Ne) and positivity
(Pe). Brain Res Cogn Brain Res 2004;20:294-9.
49. van Veen V, Carter CS. The anterior cingulate as a conflict moni-
tor: fMRI and ERP studies. Physiol Behav 2002;77:477-82.
50. Miltner WH, Lemke U, Weiss T, et al. Implementation of error-
processing in the human anterior cingulate cortex: a source analy-
sis of the magnetic equivalent of the error-related negativity. Biol
Psychol 2003;64:157-66.
51. Falkenstein M., Hoormann J., Christ S., et al. ERP components on
reaction errors and their functional significance: a tutorial. Biol
Psychol 2000;51:87-107.
52. Wessel JR, Danielmeier C, Ullsperger M. Error awareness revisit -
ed: accumulation of multimodal evidence from central and auto-
nomic nervous systems. J Cogn Neurosci 2011;23:3021-36.
53. Ridderinkhof KR, Ramautar JR, Wijnen JG, et al. E) or not to P(E):
a P3-like ERP component reflecting the processing of response er-
rors. Psychophysiology 2009;46:531-8.
54. Holroyd CB, Krigolson OE, Baker R, et al. When is an error not a
prediction error? An electrophysiological investigation. Cogn Affect
Behav Neurosci 2009;9:59-70.
55. Brown JW, Braver TS. Learned predictions of error likelihood in
the anterior cingulate cortex. Science 2005;307:1118-21.
56. Magno E, Foxe JJ, Molholm S, et al. The anterior cingulate and er-
ror avoidance. J Neurosci 2006;26:4769-73.
57. Hester R, Fassbender C, Garavan H. Individual differences in error
processing: a review and reanalysis of three event-related fMRI
studies using the go/nogo task. Cereb Cortex 2004;14:986-94.
58. Menon V, Adleman NE, White CD, et al. Error-related brain acti-
vation during a go/nogo response inhibition task. Hum Brain
Mapp 2001;12:131-43.
59. Kerns JG, Cohen JD, MacDonald AW, et al. Anterior cingulate con-
flict monitoring and adjustments in control. Science 2004;303:
1023-6.
60. Evans DE, Park JY, Maxfield N, et al. Neurocognitive variation in
smoking behavior and withdrawal: genetic and affective modera-
tors. Genes Brain Behav 2009;8:86-96.
61. Luijten M, Littel M, Franken IHA. Deficits in inhibitory control in
smokers during a go/nogo task: an investigation using event-re-
lated brain potentials. PLoS ONE 2011;6:e18898.
62. de Ruiter MB, Oosterlaan J, Veltman DJ, et al. Similar hyporespon-
siveness of the dorsomedial prefrontal cortex in problem gamblers
and heavy smokers during an inhibitory control task. Drug Alcohol
Depend 2012;121:81-9.
63. Nestor L, McCabe E, Jones J, et al. Differences in “bottom-up” and
“top-down” neural activity in current and former cigarette smok-
ers: evidence for neural substrates which may promote nicotine
abstinence through increased cognitive control. Neuroimage
2011;56:2258-75.
64. Galván A, Poldrack RA, Baker CM, et al. Neural correlates of re-
sponse inhibition and cigarette smoking in late adolescence. 
Neuropsychopharmacology 2011;36:970-8.
65. Luijten M, Veltman DJ, Hester R, et al. The role of dopamine in in-
hibitory control in smokers and non-smokers: a pharmacological fMRI
study. Eur Neuropsychopharmacol 2012 Nov. 26 [Epub ahead of print]. 
66. Berkman ET, Falk EB, Lieberman MD. In the trenches of real-
world self-control: neural correlates of breaking the link between
craving and smoking. Psychol Sci 2011;22:498-506.
67. Kamarajan C, Porjesz B, Jones KA, et al. Alcoholism is a disin-
hibitory disorder: neurophysiological evidence from a go/no-go
task. Biol Psychol 2005;69:353-73.
68. Cohen HL, Porjesz B, Begleiter H, et al. Neurophysiological cor -
relates of response production and inhibition in alcoholics. Alcohol
Clin Exp Res 1997;21:1398-406.
69. Colrain IM, Sullivan EV, Ford JM, et al. Frontally mediated in-
hibitory processing and white matter microstructure: age and alco-
holism effects. Psychopharmacology (Berl) 2011;213:669-79.
70. Pfefferbaum A, Rosenbloom M, Ford JM. Late event-related poten-
tial changes in alcoholics. Alcohol 1987;4:275-81.
71. Karch S, Graz C, Jager L, et al. Influence of anxiety on electro -
physio logical correlates of response inhibition capacities in alco-
holism. Clin EEG Neurosci 2007;38:89-95.
72. Fallgatter AJ, Wiesbeck GA, Weijers HG, et al. Event-related cor -
rel ates of response suppression as indicators of novelty seeking in
alcoholics. Alcohol Alcohol 1998;33:475-81.
73. Pandey AK, Kamarajan C, Tang Y, et al. Neurocognitive deficits in
male alcoholics: an ERP/sLORETA analysis of the N2 component
in an equal probability go/nogo task. Biol Psychol 2012;89:170-82.
74. Karch S, Jager L, Karamatskos E, et al. Influence of trait anxiety on in-
hibitory control in alcohol-dependent patients: simultaneous acquisi-
tion of ERPs and BOLD responses. J Psychiatr Res 2008;42:734-45.
75. Li CS, Luo X, Yan P, et al. Altered impulse control in alcohol
 dependence: neural measures of stop signal performance. Alcohol
Clin Exp Res 2009;33:740-50.
76. Schmaal L, Joos L, Koeleman M, et al. Effects of modafinil on
neural correlates of response inhibition in alcohol-dependent pa-
tients. Biol Psychiatry 2013;73:211-8.
77. Rubio G, Jimenez M, Rodriguez-Jimenez R, et al. The role of be-
havioral impulsivity in the development of alcohol dependence: a
4-year follow-up study. Alcohol Clin Exp Res 2008;32:1681-7.
78. Lawrence AJ, Luty J, Bogdan NA, et al. Impulsivity and response
inhibition in alcohol dependence and problem gambling. 
Psychopharmacology (Berl) 2009;207:163-72.
79. Fishbein DH, Krupitsky E, Flannery BA, et al. Neurocognitive
characterizations of Russian heroin addicts without a significant
history of other drug use. Drug Alcohol Depend 2007;90:25-38.
80. Noël X, Van der Linden M, d’Acremont M, et al. Alcohol cues in-
crease cognitive impulsivity in individuals with alcoholism. 
Psychopharmacology (Berl) 2007;192:291-8.
81. Hester R, Nestor L, Garavan H. Impaired error awareness and an-
terior cingulate cortex hypoactivity in chronic cannabis users. 
Neuropsychopharmacology 2009;34:2450-8.
82. Tapert SF, Schweinsburg AD, Drummond SP, et al. Functional
MRI of inhibitory processing in abstinent adolescent marijuana
users. Psychopharmacology (Berl) 2007;194:173-83.
83. Takagi M, Lubman DI, Cotton S, et al. Executive control among
adolescent inhalant and cannabis users. Drug Alcohol Rev 2011;30:
629-37.
84. Grant JE, Chamberlain SR, Schreiber L, et al. Neuropsychological
deficits associated with cannabis use in young adults. Drug Alcohol
Depend 2012;121:159-62.
85. Sokhadze E, Stewart C, Hollifield M, et al. Event-related potential
study of executive dysfunctions in a speeded reaction task in co-
caine addiction. J Neurother 2008;12:185-204.
86. Hester R, Garavan H. Executive dysfunction in cocaine addiction:
evidence for discordant frontal, cingulate, and cerebellar activity.
J Neurosci 2004;24:11017-22.
87. Kaufman JN, Ross TJ, Stein EA, et al. Cingulate hypoactivity in co-
caine users during a go-nogo task as revealed by event-related
functional magnetic resonance imaging. J Neurosci 2003;23:7839-43.
88. Li CS, Huang C, Yan P, et al. Neural correlates of impulse control
during stop signal inhibition in cocaine-dependent men. Neuro -
psychopharmacology 2008;33:1798-806.
89. Luo X, Zhang S, Hu S, et al. Error processing and gender-shared
and -specific neural predictors of relapse in cocaine dependence.
Brain 2013;136:1231-44.
90. Li CS, Morgan PT, Matuskey D, et al. Biological markers of the effects
of intravenous methylphenidate on improving inhibitory control in
cocaine-dependent patients. Proc Natl Acad Sci U S A 2010;107:14455-9.
91. Leland DS, Arce E, Miller DA, et al. Anterior cingulate cortex and
benefit of predictive cueing on response inhibition in stimulant
 dependent individuals. Biol Psychiatry 2008;63:184-90.
92. Yang B, Yang S, Zhao L, et al. Event-related potentials in a
go/nogo task of abnormal response inhibition in heroin addicts.
Sci China C Life Sci 2009;52:780-8.
93. Fu LP, Bi G, Zou Z, et al. Impaired response inhibition function in
abstinent heroin dependents: an fMRI study. Neurosci Lett 2008;
438:322-6.
94. Zhou Z, Yuan G, Yao J, et al. An event-related potential investiga-
tion of deficient inhibitory control in individuals with pathological
Internet use. Acta Neuropsychiatr 2010;22:228-36.
95. Dong G, Lu Q, Zhou H, et al. Impulse inhibition in people with in-
ternet addiction disorder: electrophysiological evidence from a
go/nogo study. Neurosci Lett 2010;485:138-42.
96. Littel M, van den Berg I, Luijten M, et al. Error processing and re-
sponse inhibition in excessive computer game players: an event-
related potential study. Addict Biol 2012;17:934-47.
97. van Holst RJ, Van Holstein M, Van den Brink W, et al. Response
inhibition during cue reactivity in problem gamblers: an fMRI
study. PLoS ONE 2012;7:e30909.
98. Hendrick OM, Luo X, Zhang S, et al. Saliency processing and obe-
sity: a preliminary imaging study of the stop signal task. Obesity
(Silver Spring) 2012;20:1796-802.
99. Lock J, Garrett A, Beenhakker J, et al. Aberrant brain activation
during a response inhibition task in adolescent eating disorder
subtypes. Am J Psychiatry 2011;168:55-64.
100. Franken IH, Van Strien JW, Kuijpers I. Evidence for a deficit in the
salience attribution to errors in smokers. Drug Alcohol Depend
2010;106:181-5.
101. Luijten M, Van Meel CS, Franken IHA. Diminished error process-
ing in smokers during smoking cue exposure. Pharmacol Biochem
Behav 2011;97:514-20.
102. Padilla ML, Colrain IM, Sullivan EV, et al. Electrophysiological
evi dence of enhanced performance monitoring in recently absti-
nent alcoholic men. Psychopharmacology (Berl) 2011;213:81-91.
103. Schellekens AF, De Bruijn ER, Van Lankveld CA, et al. Alcohol de-
pendence and anxiety increase error-related brain activity. Addiction
2010;105:1928-34.
104. Olvet DM, Hajcak G. The error-related negativity (ERN) and
psycho pathology: toward an endophenotype. Clin Psychol Rev
2008;28:1343-54.
105. Marhe R, van de Wetering BJM, Franken IHA. Error-related brain
activity predicts cocaine use after treatment at 3-month follow-up.
Biol Psychiatry 2013;73:782-8.
106. Forman SD, Dougherty GG, Casey BJ, et al. Opiate addicts lack
 error-dependent activation of rostral anterior cingulate. Biol 
Psychiatry 2004;55:531-7.
107. Goldstein RZ, Craig AD, Bechara A, et al. The neurocircuitry of
impaired insight in drug addiction. Trends Cogn Sci 2009;13:372-80.
108. Schweinsburg AD, Schweinsburg BC, Medina KL, et al. The  
Luijten et al.
168 J Psychiatry Neurosci 2014;39(3)
Inhibitory control and error processing in  substance dependence and behavioural addictions
J Psychiatry Neurosci 2014;39(3) 169
influence of recency of use on fMRI response during spatial working
memory in adolescent marijuana users. J Psychoactive Drugs
2010;42:401-12.
109. Baillie AJ, Stapinski L, Crome E, et al. Some new directions for re-
search on psychological interventions for comorbid anxiety and
substance use disorders. Drug Alcohol Rev 2010;29:518-24.
110. Bacon AK, Ham LS. Attention to social threat as a vulnerability to
the development of comorbid social anxiety disorder and alcohol
use disorders: an avoidance-coping cognitive model. Addict Behav
2010;35:925-39.
111. van Noordt SJ, Segalowitz SJ. Performance monitoring and the
medial prefrontal cortex: a review of individual differences and
context effects as a window on self-regulation. Front Hum Neurosci
2012;6:197.
112. Botvinick MM, Cohen JD, Carter CS. Conflict monitoring and
anter ior cingulate cortex: an update. Trends Cogn Sci 2004;8:539-46.
113. Dom G, De Wilde B. Controleverlies. In: Franken IHA, van den
Brink W, editors. Handboek Verslaving. 1st ed. Utrecht: De Tijd-
stroom uitgeverij; 2009. p. 209–227.
114. Euser A.S., Arends L.R., Evans B.E., et al. The P300 event-related
brain potential as a neurobiological endophenotype for substance
use disorders: a meta-analytic investigation. Neurosci Biobehav Rev
2012;36:572-603.
115. Chao HH, Luo X, Chang JL, et al. Activation of the pre-
 supplementary motor area but not inferior prefrontal cortex in as-
sociation with short stop signal reaction time — an intra-subject
analysis. BMC Neurosci 2009;10:75.
116. Wilkinson D, Halligan P. The relevance of behavioural measures
for functional-imaging studies of cognition. Nat Rev Neurosci
2004;5:67-73.
117. Goh JO, Park DC. Neuroplasticity and cognitive aging: the scaf-
folding theory of aging and cognition. Restor Neurol Neurosci
2009;27:391-403.
118. Connolly CG, Foxe JJ, Nierenberg J, et al. The neurobiology of cog-
nitive control in successful cocaine abstinence. Drug Alcohol 
Depend 2012;121:45-53.
119. Chen A, Bailey K, Tiernan BN, et al. Neural correlates of stimulus
and response interference in a 2-1 mapping stroop task. Int J 
Psychophysiol 2011;80:129-38.
120. Atkinson CM, Drysdale KA, Fulham WR. Event-related potentials
to Stroop and reverse Stroop stimuli. Int J Psychophysiol 2003;47:1-21.
121. Larson MJ, Kaufman DA, Perlstein WM. Neural time course of
conflict adaptation effects on the Stroop task. Neuropsychologia
2009;47:663-70.
122. Salo R, Ursu S, Buonocore MH, et al. Impaired prefrontal cortical
function and disrupted adaptive cognitive control in methamphet-
amine abusers: a functional magnetic resonance imaging study.
Biol Psychiatry 2009;65:706-9.
123. Potenza MN, Leung HC, Blumberg HP, et al. An FMRI Stroop task
study of ventromedial prefrontal cortical function in pathological
gamblers. Am J Psychiatry 2003;160:1990-4.
124. Bolla K, Ernst M, Kiehl K, et al. Prefrontal cortical dysfunction in ab-
stinent cocaine abusers. J Neuropsychiatry Clin Neurosci 2004;16:456-64.
125. van den Brink W, van Ree JM. Pharmacological treatments for
heroin and cocaine addiction. Eur Neuropsychopharmacol 2003; 13:
476-87.
126. Rawson RA, McCann MJ, Flammino F, et al. A comparison of con-
tingency management and cognitive-behavioral approaches for
stimulant-dependent individuals. Addiction 2006;101:267-74.
127. McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy
for substance use disorders. Psychiatr Clin North Am 2010;33:511-25.
128. Houben K, Nederkoorn C, Wiers RW, et al. Resisting temptation:
decreasing alcohol-related affect and drinking behavior by train-
ing response inhibition. Drug Alcohol Depend 2011;116:132-6.
129. Feil J, Zangen A. Brain stimulation in the study and treatment of
addiction. Neurosci Biobehav Rev 2010;34:559-74.
130. Barr MS, Fitzgerald PB, Farzan F, et al. Transcranial magnetic
stimulation to understand the pathophysiology and treatment of
substance use disorders. Curr Drug Abuse Rev 2008;1:328-39.
131. deCharms RC. Applications of real-time fMRI. Nat Rev Neurosci
2008;9:720-9.
132. Brady KT, Gray KM, Tolliver BK. Cognitive enhancers in the treat-
ment of substance use disorders: clinical evidence. Pharmacol
Biochem Behav 2011;99:285-94.
133. Severtson SG, Von Thomsen S, Hedden SL, et al. The association
between executive functioning and motivation to enter treatment
among regular users of heroin and/or cocaine in Baltimore, MD.
Addict Behav 2010;35:717-20.
134. Ersche KD, Sahakian B. The neuropsychology of amphetamine
and opiate dependence: implications for treatment. Neuropsychol
Rev 2007;17:317-36.
135. Marhe R, Luijten M, van de Wetering BJ, et al. Individual differ-
ences in anterior cingulate activation associated with attentional
bias predict cocaine use after treatment. Neuropsychopharmacology
2013;38:1085-93..
136. Euser AS, Evans BE, Greaves-Lord K, et al. Diminished error-related
brain activity as a promising endophenotype for substance-use dis-
orders: evidence from high-risk offspring. Addict Biol. In press.
